EurekaMag PDF full texts Chapter 44,072

Dawidowicz, A. 1973: Prospects for insulin therapy in diabetes. Polskie Archiwum Medycyny Wewnetrznej 50(8): 801-806

Mann, G.F.; Herrero, L.; Allison, L.M. 1980: Prospects for large scale production of thermolabile products using anchorage dependent cells. Developments in Biological Standardization 46: 289-294

Johansen, H. 1980: Prospects for leprosy control in the eighties. Nursing Journal of India 71(9): 252-253; 256

Rieckmann, K.H. 1982: Prospects for malaria blood stage vaccine. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 92(1): 77-80

Rossiter, L.F. 1984: Prospects for medical group practice under competition. Medical Care 22(1): 84-92

Cohen, G. 1981: Prospects for mental health and aging: at a crisis and crossroad. Gerontology and Geriatrics Education 1(4): 227-231

Valle, G. 1969: Prospects for modern teaching of obstetrical and gynecological clinical medicine. Minerva Medica 60(18): 765-774

Hunt, J.H. 1971: Prospects for national health insurance. Journal of Nursing Administration 1(2): 20-25

Rummelhardt, S. 1972: Prospects for nephrectomized patients. Zeitschrift für Urologie und Nephrologie 65(6): 421-438

Caplan, D. 1981: Prospects for neurolinguistic theory. Cognition 10(1-3): 59-64

McCarty, M.F. 1981: Prospects for nutritional control of hypertension. Medical Hypotheses 7(3): 271-283

Nesterova, T.B.; Isaenko, A.A.; Matveeva, N.M.; Shilov, A.G.; Rubtsov, N.B.; Vorob'eva, N.V.; Rubtsov, N.V.; Vandeberg, J.; Zakiian, S.M. 1994: Prospects for obtaining a mapping panel for somatic cell marsupial-rodent hybrids for the short-tailed opossum Monodelphis domestica. Genetika 30(11): 1516-1524

Shoshiev, L.N.; Avrorov, V.P.; Iagovkin, E.A. 1980: Prospects for obtaining nontoxic bacterial endotoxins. Antibiotiki 25(1): 67-73

Gerbaulet, A.; Péjovic, M.H.; Chassagne, D. 1980: Prospects for para-aortic irradiation in carcinoma of the uterine cervix. Bulletin du Cancer 67(1): 39-41

Taylor, C.E. 1973: Prospects for practical population programs. International Journal of Health Services: Planning Administration Evaluation 3(4): 869-875

Plummer, E.M. 1969: Prospects for practice: the focus. Ana Clinical Conferences 1969: 3-4

Brindle, J. 1969: Prospects for prepaid group practice. American Journal of Public Health and the Nation's Health 59(Suppl 1): 37-45

MacLeod, G.K. 1969: Prospects for prepaid group practice. Summary of general discussion. American Journal of Public Health and the Nation's Health 59 Suppl. 1: 52-53

Doll, R. 1983: Prospects for prevention. British Medical Journal 286(6363): 445-453

Huang, M.J. 1974: Prospects for prevention and control of CVA and hypertension in the community. Hu Li Za Zhi Journal of Nursing 21(2): 16-18

Navia, J.M. 1973: Prospects for prevention of dental caries: dietary factors. Journal of the American Dental Association 87(5): 1010-1012

Seldon, A. 1967: Prospects for private health insurance. British Medical Journal 3(5558): 166-168

Petrovskaia, V.G. 1980: Prospects for production of improved preparations of preventing infectious diseases. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1980(5): 61-69

TeKolste, E. 1972: Prospects for prospective payment. Hospitals 46(10): 56-58

Sharry, J. 1970: Prospects for prosthodontics. Journal of Prosthetic Dentistry 23(2): 232-238

Wagner, P.S. 1969: Prospects for psychiatry and psychoanalysis. International Psychiatry Clinics 6(3): 5-28

Rangell, L. 1974: Prospects for psychoanalysis. Observations on threatening decline of integrity. Psyche 28(11): 933-950

Gomperts, C.E. 1968: Prospects for radiation treatment of herpetic and other affections of the anterior segment of the eye. Ophthalmologica. Journal International D'ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 155(2): 130-140

Omenn, G.S.; Figley, M.M.; Graham, C.B.; Heinrichs, W.L. 1973: Prospects for radiographic intrauterine diagnosis--the syndrome of thrombocytopenia with absent radii. New England Journal of Medicine 288(15): 777-778

Köhler, L.; Methfessel, H.D.; Methfessel, G. 1969: Prospects for recovery in vulvar carcinoma. (A report of 120 cases). Zentralblatt für Gynakologie 91(17): 537-541

Kaiser, E.R. 1966: Prospects for reducing particulate emissions from large incinerators. Journal of the Air Pollution Control Association 16(6): 324

Romansky, M.A. 1982: Prospects for reform of the IND/NDA processes: Part i. Journal of Clinical Psychopharmacology 2(5): 358-361

Romansky, M.A. 1982: Prospects for reform of the IND/NDA processes: part Ii. Journal of Clinical Psychopharmacology 2(6): 424-426

Spinetti, G.; Retta, V. 1984: Prospects for rehabilitation of chronic psychotic patients. Minerva Psichiatrica 25(4): 275-278

Capron, A.M. 1983: Prospects for research ethics. Progress in Clinical and Biological Research 128: 389-397

Black, G. 1981: Prospects for research libraries. Science 213(4509): 715

Ploog, D. 1972: Prospects for research on schizophrenia. 3. Neurophysiology. Breakdown of the social communication system: a key process in the development of schizophrenia?. Neurosciences Research Program Bulletin 10(4): 394-396

Teuber, H.L. 1972: Prospects for research on schizophrenia. 3. Neurophysiology. Effects of focal brain lesions. Neurosciences Research Program Bulletin 10(4): 381-384

Sackett, G.P. 1972: Prospects for research on schizophrenia. 3. Neurophysiology. Isolation-rearing in primates. Neurosciences Research Program Bulletin 10(4): 388-392

Plum, F. 1972: Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. Neurosciences Research Program Bulletin 10(4): 384-388

Hamburg, D.A. 1972: Prospects for research on schizophrenia. 3. Neurophysiology. Primate behavioral pathology under field and laboratory conditions. Neurosciences Research Program Bulletin 10(4): 392-394

Roberts, E. 1972: Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia. Neurosciences Research Program Bulletin 10(4): 468-482

Savarimuthu, K.; Sankararajan, R.; Govindaraj, R.; Narendhiran, S. 2018: A comparative study on a flexible ZnO-based nano-generator using Schottky and p-n junction contact for energy harvesting applications. Nanoscale 10(34): 16022-16029

Kety, S.S.; Matthysse, S. 1972: Prospects for research on schizophrenia. I. Introduction. Neurosciences Research Program Bulletin 10(4): 375-376

Garmezy, N. 1972: Prospects for research on schizophrenia. IV. Genetic and environmental factors. Environmental factors in the development of schizophrenia. Neurosciences Research Program Bulletin 10(4): 422-426

Cavalli-Sforza, L.L.; Kidd, K.K. 1972: Prospects for research on schizophrenia. IV. Genetic and environmental factors. Genetic models for schizophrenia. Neurosciences Research Program Bulletin 10(4): 406-419

Rosenthal, D. 1972: Prospects for research on schizophrenia. IV. Genetic and environmental factors. Hereditary nature of schizophrenia. Neurosciences Research Program Bulletin 10(4): 397-403

Neel, J. 1972: Prospects for research on schizophrenia. IV. Genetic and environmental factors. Parallels in medicine. Neurosciences Research Program Bulletin 10(4): 403-406

Kagan, J. 1972: Prospects for research on schizophrenia. IV. Genetic and environmental factors. Perceptual maturation in the infant. Neurosciences Research Program Bulletin 10(4): 427-429

Matthysse, S.; Shortliffe, L. 1972: Prospects for research on schizophrenia. IV. Genetic and environmental factors. Schizophrenia X normal matings: predictions of the polygenic model. Neurosciences Research Program Bulletin 10(4): 419-421

Snyder, S.H.; Aghajanian, G.K.; Matthysse, S. 1972: Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses. Neurosciences Research Program Bulletin 10(4): 430-445

Matthysse, S.; Smith, E.L.; Puck, T.T.; Edelman, G.M. 1972: Prospects for research on schizophrenia. VI. Biochemical hypotheses and new techniques. Neurosciences Research Program Bulletin 10(4): 446-455

Kety, S.S. 1972: Prospects for research on schizophrenia. VII. Prospects for research in schizophrenia. An overview. Neurosciences Research Program Bulletin 10(4): 456-467

Izmerov, N.F.; Kaptsov, V.A. 1985: Prospects for research on the occupational hygiene of health workers. Sovetskoe Zdravookhranenie 9: 19-21

Harwin, B.G.; Cooper, B.; Eastwood, M.R.; Goldberg, D.P. 1970: Prospects for social work in general practice. Lancet 2(7672): 559-561

Abraĭtis, R.I.; Stropus, R.A. 1981: Prospects for studying myocardial contractility in human autopsy material. Biulleten' Eksperimental'noi Biologii i Meditsiny 91(1): 6-7

Alekseev, A.N.; Detinova, T.S.; Shipitsina, N.K. 1974: Prospects for studying the biology and ecology of blood-sucking Diptera in a period of limiting the mass use of pesticides. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 43(5): 515-520

Bonashevskaia, T.I.; Chursov, V.A. 1984: Prospects for studying the endocrine apparatus of the gastrointestinal tract in setting hygienic standards for chemical compounds in the drinking water. Gigiena i Sanitariia 6: 60-62

Gritsenko, O.M.; Lapinina, L.A. 1974: Prospects for studying the sucrose-decreasing action of bean preparations. Farmatsevtychnyi Zhurnal 29(5): 85-87

Gorbatiuk, D.L.; Raĭtsina, S.S.; Stechenko, L.A.; Petrosian, Z.L. 1980: Prospects for surgical correction of male endocrine and reproductive failure. Klinicheskaia Khirurgiia 1980(12): 12-14

Ashmarin, I.P. 1984: Prospects for the application and basic research on small regulatory peptides. Voprosy Meditsinskoi Khimii 30(3): 2-7

Wartak, J.; Panasewicz, J. 1965: Prospects for the application of computers in differential diagnosis. Polskie Archiwum Medycyny Wewnetrznej 35(4): 559-564

Green, H. 1969: Prospects for the chromosomal localization of human genes in human-mouse somatic cell hybrids. Wistar Institute Symposium Monograph 9: 51-59

Katz, D.H. 1980: Prospects for the clinical control of IgE synthesis. Progress in Clinical Immunology 4: 127-150

Witter, R.L.; Solomon, J.J. 1971: Prospects for the control of Marek's disease through isolation rearing. Progress in Immunobiological Standardization 5: 163-168

Howard, R.J. 1982: Prospects for the control of host defenses. Surgery 92(2): 138-145

Davenport, F.M. 1969: Prospects for the control of influenza. American Journal of Nursing 69(9): 1908-1911

Browne, S.G. 1983: Prospects for the control of leprosy in Papua new Guinea. Papua and new Guinea Medical Journal 26(1): 1-3

Fisher, B. 1969: Prospects for the control of metastases. Cancer 24(6): 1263-1269

Stoianov, A. 1983: Prospects for the development and dissemination of invention and innovation in the field of veterinary medicine. Veterinarno-Meditsinski Nauki 20(10): 60-65

Kovalevskiĭ, E.I.; Lomakin, L.N.; Nesterov, A.P. 1983: Prospects for the development and manufacture of an apparatus for studying the visual field. Vestnik Oftalmologii 1: 55-58

Kalamkarov, K.A.; Nikitin, O.P.; Karal'nik, D.M.; Shteĭngart, M.Z.; Glazov, O.D. 1982: Prospects for the development and orthodontic introduction of prostheses made of porcelain and metal-ceramics. Stomatologiia 61(3): 51-53

Cravioto, A. 1984: Prospects for the development of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (3). Boletin Medico del Hospital Infantil de Mexico 41(5): 253-261

Pafomov, G.A.; Rusanov, V.M.; Belova, T.A.; Khvatov, V.B.; Merzlov, V.P. 1982: Prospects for the development of an antiproteinase agent on the basis of human alpha 2-macroglobulin. Problemy Gematologii i Perelivaniia Krovi 27(4): 23-27

Votiakov, V.I. 1980: Prospects for the development of experimental antiviral therapy. Vestnik Akademii Meditsinskikh Nauk SSSR 1980(10): 3-10

Shvedov, K.P. 1981: Prospects for the development of general anesthesia in dentistry. Voenno-Meditsinskii Zhurnal 3: 23-26

Agadzhanian, G.I.; Topchian, Z.S.; Petrosian, O.K.; Karapetian, G.G. 1972: Prospects for the development of health resort science in the Armenian Soviet Socialist Republic. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 37(6): 507-511

Zaporozhan, V.N. 1984: Prospects for the development of immunological studies with regard to hyperplastic processes in the reproductive system. Akusherstvo i Ginekologiia 11: 16-20

Chikin, S.I.; Cheknev, B.M.; Ivanov, V.K. 1972: Prospects for the development of medical education below the academic level in the Russian Federation. Zdravookhranenie Rossiiskoi Federatsii 16(2): 3-7

Krasovskiĭ, G.N.; Egorova, N.A. 1980: Prospects for the development of methods of predicting safe substance levels based on "structure-activity" relationships. Vestnik Akademii Meditsinskikh Nauk SSSR 7: 88-95

Korzh, A.A.; Logachev, K.D. 1972: Prospects for the development of modern orthopedics. Ortopediia Travmatologiia i Protezirovanie 33(3): 53-58

Durinian, R.A.; Zol'nikov, S.M.; Polianskaia, Z.M.; Oreshenkov, M.M.; Sergeeva, T.I. 1982: Prospects for the development of reflexotherapy in the USSR. Sovetskoe Zdravookhranenie 6: 7-10

Shmelev, N.A. 1971: Prospects for the development of scientific research in phthisiology. Problemy Tuberkuleza 49(1): 20-24

Stoliarova, L.G.; Kadykov, A.S. 1984: Prospects for the development of scientific research in the area of rehabilitative treatment of post-infarct patients. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(8): 1121-1126

Treskunov, A.A. 1973: Prospects for the development of technical means for sanitary hygiene and sanitary bacteriology research. Meditsinskaia Tekhnika 1: 41-42

Lisitsyn, K.M.; Kokhan, E.P. 1973: Prospects for the development of vascular surgery. Voenno-Meditsinskii Zhurnal 11: 19-21

Foresti, A. 1971: Prospects for the diagnostic use of dopamine in coronary insufficiency. Giornale Italiano di Cardiologia 1(2): 122-130

Peterson, B.E.; Kuz'min, I.V. 1982: Prospects for the early diagnosis and treatment of lung cancer. Sovetskaia Meditsina 2: 87-91

Cravioto, A. 1984: Prospects for the elaboration of an anti-adhesive vaccine against Escherichia coli strains causing diarrhea in humans. 2. Boletin Medico del Hospital Infantil de Mexico 41(4): 188-196

Anonymous 1969: Prospects for the elimination of measles. Voprosy Virusologii 14(2): 248

Chambon, L. 1980: Prospects for the future in the control of malaria. Bulletin de l'Academie Nationale de Medecine 164(1): 94-102

Langfitt, T.W.; Gennarelli, T.A.; Obrist, W.D.; Bruce, D.A.; Zimmerman, R.A. 1982: Prospects for the future in the diagnosis and management of head injury: pathophysiology, brain imaging, and population-based studies. Clinical Neurosurgery 29: 353-376

Kupriianov, V.V. 1985: Prospects for the growth of scientific research in morphology during the 12th Five-Year-Plan. Arkhiv Anatomii Gistologii i Embriologii 89(10): 5-13

Men'shov, A.A.; Cherniuk, V.I. 1984: Prospects for the hygienic improvement of tractors and self-propelled agricultural machinery. Gigiena Truda i Professional'nye Zabolevaniya (9): 17-20

Nazarov, G.N.; Makarenko, T.F. 1982: Prospects for the introduction of spectral methods into forensic medical casework. Sudebno-Meditsinskaia Ekspertiza 25(1): 30-32

Bondarenko, N.G. 1982: Prospects for the legal protection of plant and animal cell cultures. Tsitologiia 24(11): 1367-1373

Boland, J.; Legrand, V. 1983: Prospects for the limitation of the size of acute myocardial infarction. Revue Medicale de Liege 38(24): 915-926

Kruse, M. 1973: Prospects for the next 4 years. Tidskrift for Sveriges Sjukskoterskor 40(14): 47

Haygood, V.P.; Wahbeh, C.J. 1983: Prospects for the prenatal diagnosis and obstetric management of cloacal exstrophy. A report of two cases. Journal of Reproductive Medicine 28(11): 807-810

Khachadurian, A.K. 1973: Prospects for the prenatal diagnosis of familial hypercholesterolemia. Le Journal Medical Libanais. Lebanese Medical Journal 26(4): 325-329

Danks, D.M. 1973: Prospects for the prevention of genetic disease. Medical Journal of Australia 1(12): 573-577

Lemkau, P.V. 1966: Prospects for the prevention of mental illnesses. Mental Hygiene 50(2): 172-179

Cravioto, A. 1984: Prospects for the production of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (1). Boletin Medico del Hospital Infantil de Mexico 41(3): 122-128

Nazarenko, V.V. 1968: Prospects for the sanitary protection of the Samara river in connection with the growth of coal mining in the western Donbass region. Gigiena i Sanitariia 33(11): 85-86

Woodman, C.B.; Prior, P.; Joseph, R.; Watson, A. 1995: Prospects for the secondary prevention of colorectal cancer: screening by flexible sigmoidoscopy?. Journal of Medical Screening 2(2): 71-78

Meshchenko, V.M.; Pronichev, N.I. 1972: Prospects for the study of bone--joint pathology from the position of medical geography. Ortopediia Travmatologiia i Protezirovanie 33(12): 15-21

Kinsbourne, M. 1967: Prospects for the study of developmental reading backwardness. British Journal of Disorders of Communication 2(2): 152-154

Zherbin, E.A. 1983: Prospects for the technical equipping of medical radiology and the tasks of clinical dosimetry. Meditsinskaia Radiologiia 28(6): 3-5

Pye, R.J. 1982: Prospects for the treatment of acne vulgaris and rosacea. Clinical and Experimental Dermatology 7(2): 195-200

Vorontsov, A.V.; Neverov, V.A. 1974: Prospects for the treatment of deformities of the bones of the extremities. Vestnik Khirurgii Imeni I. I. Grekova 112(1): 62-64

Zorzin, L.; Capone, M.; Castagnoli, M. 1980: Prospects for the use of calcitonin in aseptic osteonecrosis of the hip. La Clinica Terapeutica 95(6): 619-627

Shneĭder, V.; Sroka, P.; Sherer, B. 1970: Prospects for the use of computers for public health planning and management in the German Democratic Republic. Sovetskoe Zdravookhranenie 29(6): 45-52

Vranski, V.K.; Kardashev, T.D.; Maleev, N.S. 1971: Prospects for the use of computers in medical diagnosis. Vestnik Akademii Meditsinskikh Nauk SSSR 26(4): 60-64

Bogdanik, T. 1966: Prospects for the use of cybernetics in medicine. Polski Tygodnik Lekarski 21(36): 1355-1357

Hilleman, M.R. 1970: Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man. Journal of Infectious Diseases 121(2): 196-211

Pletnev, S.D.; Karpenko, O.M.; Semenov, O.G. 1983: Prospects for the use of gas lasers in surgery. Khirurgiia 3: 19-21

Veremeenko, K.N.; Tolstykh, P.I.; Vasil'kova, Z.F. 1981: Prospects for the use of immobilized enzymes in surgery. Sovetskaia Meditsina 1: 92-94

Styczyńska, B. 1972: Prospects for the use of insect hormone-like substance for disinfection purposes. Roczniki Panstwowego Zakladu Higieny 23(4): 495-503

Astrozhnikov, I.V.; Gureeva, K.F.; Eremina, G.V. 1982: Prospects for the use of microsurgical technics in reconstructive surgery of the esophagus. Vestnik Khirurgii Imeni I. I. Grekova 129(9): 135-139

Bondareva, Z.G.; Bredikhin, A.V.; Matveev, L.E. 1984: Prospects for the use of myoglobin radioimmunoassay. Meditsinskaia Radiologiia 29(11): 19-21

Zaorska, B. 1981: Prospects for the use of prostaglandins in pediatric cardiology. Kardiologia Polska 24(2): 167-172

Gostishchev, V.K.; Vladimirov, V.G.; Zhuravlev, A.G.; Vasil'kova, Z.F.; Zalit, S.V. 1983: Prospects for the use of protease inhibitors in acute pancreatitis. Khirurgiia 1: 66-70

Price, R.W.; Saito, Y.; Fox, J.J. 1983: Prospects for the use of radiolabeled antiviral drugs in the diagnosis of herpes simplex encephalitis. Biochemical Pharmacology 32(17): 2455-2461

Khudoleĭ, V.V.; Pliss, G.B. 1984: Prospects for the use of short-term tests in primary cancer prevention. Voprosy Onkologii 30(8): 3-12

Komarov, F.I.; Gladyshev, G.P.; Tsepalov, V.F. 1983: Prospects for the use of the methods of simulated chain reactions in modern therapy, pharmacology and pharmacy. Vestnik Akademii Meditsinskikh Nauk SSSR 4: 81-89

Cermák, J. 1973: Prospects for the use, of spiroergometry in medical branches. Methodic problems. Casopis Lekaru Ceskych 112(37): 1126-1129

Ruderman, A.I.; Vaĭnberg, M.S.; Bibergal', A.V.; Nikulin, I.P. 1968: Prospects for the utilization of cesium isotopes in telecurietherapy of oncological patients. Vestnik Akademii Meditsinskikh Nauk SSSR 23(6): 49-53

Armand, J. 1983: Prospects for the vaccinal prevention of Haemophilus influenzae type b meningitis. Pathologie-Biologie 31(2): 144-148

Borisov, E.A. 1980: Prospects for thermography in the diagnosis of tumors. Meditsinskaia Tekhnika 4: 26-28

Marshall, V. 1981: Prospects for training of Australian surgeons in Britain. Australian and New Zealand Journal of Surgery 51(3): 251-256

Bilibin, A.F.; Pogorel'skaia, L.V.; Markova, E.A.; Gogol', L.G.; Teleshevskaia, E.A. 1972: Prospects for treating chronic carriers of typhoid fever. Sovetskaia Meditsina 35(5): 24-27

Elsbach, P.; Weiss, J. 1995: Prospects for use of recombinant BPi in the treatment of gram-negative bacterial infections. Infectious Agents and Disease 4(2): 102-109

Popov, N.A.; Vershinin, P.V.; Ponomarenko, V.F. 1974: Prospects for use of the preparation diphos for medical insect control. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 00(5): 127-128

Babaiants, R.S.; Shibamov, V.A.; Shpilevaia, L.I. 1980: Prospects for using adaptogen preparations in dermatology. Vestnik Dermatologii i Venerologii 5: 4-10

Kogut, G.I.; Khudzinskiĭ, V.M. 1984: Prospects for using an apparatus with a 2-stage choke cooling system for bone marrow preservation. Gematologiia i Transfuziologiia 29(11): 57-60

Shumakov, V.I. 1980: Prospects for using an artificial endocrine pancreas, donor pancreas and a beta-cell culture in the surgical treatment of diabetes mellitus. Vestnik Akademii Meditsinskikh Nauk SSSR 7: 18-25

Mintser, O.P.; Zakharov, V.P.; Knyshov, G.V.; Ugarov, B.N.; Romashko, N.P. 1981: Prospects for using and experience in creating microcontroller--based devices for the processing of clinical information. Meditsinskaia Tekhnika 6: 47-49

Blinova, L.P. 1984: Prospects for using bacteriocins for the prevention and therapy of infections. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1984(5): 10-14

Druzhinina, L.V. 1980: Prospects for using canned products in the nutrition of children in different age groups. Pediatriia 11: 3-5

Gorovoi, B.I.; Shteingart, M.Z.; Bliakhman, E.M.; Ivanov, V.S.; Afanas'eva, M.I. 1972: Prospects for using epoxy resins in dentistry. Meditsinskaia Tekhnika 5: 27-30

Sagalovich, B.M.; Melkumova, G.G. 1972: Prospects for using evoked potentials in evaluation of the functional state of the auditory analyzer. Vestnik Otorinolaringologii 34(5): 21-26

Fedotov, A.F. 1974: Prospects for using histochemical and electron microscopic methods of analysis in otorhinolaryngology. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 1: 122-125

Amosov, I.S.; Kugel'mas, M.K.; Nalimov, I.P.; Shakirov, A.K. 1981: Prospects for using holography in roentgenology. Vestnik Rentgenologii i Radiologii 4: 84-89

Bazhanov, N.N.; Efuni, S.N.; Genkin, M.E.; Drozhzhin, A.P. 1980: Prospects for using hyperbaric oxygenation in stomatology. Stomatologiia 59(6): 75-78

Danilevskiĭ, N.F.; Khomenko, L.A.; Sidel'nikova, L.F. 1983: Prospects for using immobilized enzymes in dentistry. Stomatologiia 62(3): 32-34

Kiselev, I.M.; Dubrovskiĭ, G.P.; Mosidze, T.G.; Bazhanov, A.I. 1983: Prospects for using implanted systems of assisted circulation and artificial heart with a radioisotope power source (biomedical, thermal, and radiation aspects). Artificial Organs 7(1): 117-121

Alekseev, A.N. 1984: Prospects for using integrated methods of controlling blood-sucking arthropods in light of the solutions to the most important economic tasks. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 1: 3-5

Rozenberg, O.A.; Aliiakparov, M.T.; Khanson, K.P.; Davidenkova, E.F.; Zherbin, E.A. 1981: Prospects for using liposomes in experimental clinical radiology. Meditsinskaia Radiologiia 26(5): 65-69

Babaiants, R.S.; Tishchenko, L.D.; Venediktova, N.D. 1973: Prospects for using medicinal plants in the dermatologist's practice. Vestnik Dermatologii i Venerologii 47(12): 13-16

Smirnova-Mutusheva, M.A.; Godovannyi, B.A. 1969: Prospects for using methods of colicin typing and colicinogeny typing of pathogenic enterobacteriaceae in epidemiologic practice (review). Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 46(6): 46-49

Astrozhnikov, I.V.; Eremina, G.V.; Gureeva, K.F. 1982: Prospects for using microsurgical technics in abdominal surgery. Vestnik Khirurgii Imeni I. I. Grekova 128(3): 144-147

Sidorik, E.P.; Burlaka, A.P.; Sirdorik, O.A.; Korchevaia, L.M. 1984: Prospects for using platinum coordination compounds possessing antitumor activity. Eksperimental'naia Onkologiia 6(6): 6-12

Linnik, L.A.; Usov, N.I.; Chechin, P.P.; Pelepchuk, O.S. 1982: Prospects for using stimulating laser therapy in ophthalmology. Oftalmologicheskii Zhurnal 37(4): 193-197

Kiseleva, V.N.; Ruderman, A.I.; Lebedev, A.I. 1983: Prospects for using the Institute of Theoretical and Experimental Physics proton beam for treating gynecologic cancer patients. Voprosy Onkologii 29(6): 34-41

Koreshkova, S.V.; Tanirbergenov, T.B.; Tarasov, V.A. 1995: Prospects for using the SOS-Chromotest for predicting carcinogenic activity of chemical compounds. Genetika 31(6): 861-864

Antipenko, E.N.; Timchenko, O.I. 1984: Prospects for using the ana-telophase method for cytogenetic analysis rat of liver cells in hygienic research. Gigiena i Sanitariia 4: 65-68

Savel'ev, V.S.; Zatevakhin, I.I.; Loshchilov, V.I.; Isaev, A.F.; Savrasov, G.V. 1982: Prospects for using ultrasound in the treatment of acute arterial thrombosis. Khirurgiia 2: 89-93

Krugman, S. 1967: Prospects for vaccination against rubella. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 63(1): 8-12

Robin, B. 1972: They don't want to go home from the hospital. Sygeplejersken 72(23): 4-7

Jordan, W.S. 1984: Prospects for worldwide control of paralytic poliomyelitis: a discussion. Reviews of Infectious Diseases 6 Suppl. 2: S594-S595

Pochin, E.E. 1967: Prospects from the treatment of thyroid carcinoma with radioiodine. Clinical Radiology 18(2): 113-125

Shimada, K. 1981: Prospects in antibiotic treatment of internal diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 58-65

Oishi, M. 1981: Prospects in antibiotic treatment of ophthalmologic diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 92-97

Naide, Y. 1981: Prospects in antibiotic treatment of urologic diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 85-91

Sherry, S. 1972: Prospects in antithrombotic therapy. American Journal of Cardiology 29(1): 81-89

Orange, R.P.; Austen, K.F. 1968: Prospects in asthma therapy: disodium cromoglycate and diethylcarbamazine. New England Journal of Medicine 279(19): 1055-1057

Budak, A.P. 1971: Prospects in elaboration of aerosol immnnization method. Fel'dsher i Akusherka 36(1): 45-47

Lipsett, M.B. 1969: Prospects in endocrinology for chemotherapy. Cancer Research 29(12): 2408-2411

Adam, J.; Werner, K. 1971: Prospects in evaluation of the quality of medical care. Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 17(6): 421-424

Anonymous 1967: Prospects in general practice. South African Medical Journal 41(28): 685-686

Van Rood, J.J.; Van Leeuwen, A.; Freudenberg, J.; Rubinstein, P. 1971: Prospects in host-donor matching. Transplantation Proceedings 3(2): 1042-1050

Jones, B.R. 1971: Prospects in immunogenic disease of the outer eye. Transactions of the Ophthalmological Societies of the United Kingdom 91: 509-513

Taggart, M.E. 1984: Prospects in information services for nursing care. L' Infirmiere Canadienne 26(9): 20-22

Krim, M. 1981: Prospects in interferon research. Texas Reports on Biology and Medicine 41: 681-692

Kingrey, B.W. 1965: Prospects in large animal practice. Canadian Veterinary Journal 6(9): 215-219

De Jode, L.R. 1982: Prospects in large bowel cancer. Journal of the Royal Society of Medicine 75(5): 301-303

Wilson, R.M. 1969: Prospects in laser chemistry. Annals of the new York Academy of Sciences 168(3): 615-620

Paoletti, P.; Schiffer, D. 1984: Prospects in neuro-oncology. Minerva Medica 75(21): 1255-1257

Rejhonová, M. 1973: Prospects in physical culture. Casopis Lekaru Ceskych 112(22): 697

Lewis, D.J.; Lehmann, H.E. 1970: Prospects in postgraduate education in psychiatry. Canadian Psychiatric Association Journal 15(6): 587-592

Doherty, N.J. 1972: Prospects in practice location. New York State Dental Journal 38(3): 142-144

Cernescu, C. 1970: Prospects in standardization and control of viral vaccines. Studii Si Cercetari de Inframicrobiologie 21(4): 303-322

Dempster, W.J. 1970: Prospects in surgical research. Lancet 2(7685): 1259-1260

Minkowski, A. 1965: Prospects in the biology of the human fetus. La Revue du Praticien 15(31 Suppl): 22-23

Pagani, I.; Ramaioli, F.; Mapelli, A. 1974: Prospects in the clinical use of Ketamine chlorhydrate in pediatric orthopedics and traumatology. Minerva Anestesiologica 40(4): 159-162

Pierquin, B.; Julien, M. 1983: Prospects in the conservative treatment of breast cancers. Presse Medicale 12(32): 1967-1968

Guttmacher, A.F. 1973: Prospects in the control of conception. Ippf Medical Bulletin 7(5): 1-3

Umezawa, H. 1981: Prospects in the development of antibiotic agents. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 5-9

Toyoshima, S. 1981: Prospects in the development of antiviral agents. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(6): 2364-2369

Blazek, J. 1971: Prospects in the development of pharmaceutical services and goals of pharmaceutical science in the USSR for the years 1971-1975. Ceskoslovenska Farmacie 20(9): 323-325

Cortissone, C.; Ilari, O.; Lembo, G.; Prodi, V.; Melandri, C. 1968: Problems of air pollution control in an establishment manufacturing conbustible for nuclear reactors. Minerva Fisiconucleare 12(2): 80-97

Rimondi, O. 1968: Prospects in the field of personal radiation dosimetry. Minerva Fisiconucleare 12(2): 49

Focà, A. 1980: Prospects in the field of the antipolio vaccination. Annali Sclavo; Rivista di Microbiologia E di Immunologia 22(1): 22-26

Baldwin, R.W.; Glaves, D. 1972: Prospects in the immunotherapy of cancer. Recenti Progressi in Medicina 52(2): 152-170

Yokota, T. 1981: Prospects in the studies of beta-lactamase inhibitors and beta-lactamase resistant agents. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 10-17

Pérez, J.A.; Pinsker, V.S.; Wulfovich, M.; Karchmer, S. 1973: Prospects in the study of creatinine in the amniotic fluid in normal pregnancy and in the last trimester. Ginecologia y Obstetricia de Mexico 33(197): 241-249

Slama, G.; Klein, J.C.; Altman, J.J.; Tchobroutsky, G. 1981: Prospects in the treatment of insulin-dependent diabetics. La Revue du Praticien 31(9): 599-600; 605-6; 609-611

Bogush, L.K.; Zharakhovich, I.A. 1969: Prospects in the use of isolated heterologous lung in the treatment of acute pulmonary insufficiency. Grudnaia Khirurgiia 11(2): 97-99

Kavetskiĭ, R.E.; Sidorik, E.P.; Kogut, T.S.; Danko, M.I. 1968: Prospects in the use of optical quantum generators in medicine. Vrachebnoe Delo 5: 1-5

Dianzani, F.; Viano, I.; Zucca, M. 1974: Prospects in the use of the interferon system in the prevention and treatment of viral infections. Giornale Italiano di Chemioterapia 21(2): 67-78

Papenzin, L.L. 1982: Prospects in training and continued education in the recession?. Krankenpflege Journal 20(12): 30

Jones, B.R. 1967: Prospects in treating viral disease of the eye. Transactions of the Ophthalmological Societies of the United Kingdom 87: 537-579

Ronco, J. 1995: Prospects in vaccine adjuvants. Veterinary Research 26(3): 220-226

Okuyama, S.; Ito, Y.; Awano, T.; Sato, T. 1973: Prospects of 67 Ga scanning in bone neoplasms. Radiology 107(1): 123-128

Prasad, V.N. 1970: Prospects of Goswami's theory for false projection and diplopia screen. Journal of the All-India Ophthalmological Society 18(4): 183-184

Wendt-Gallitelli, M.F.; Wolburg, H.; Schlote, W.; Schwegler, M.; Holubarsch, C.; Jacob, R. 1980: Prospects of X-ray microanalysis in the study of pathophysiology of myocardial contraction. Basic Research in Cardiology 75(1): 66-72

Del Maschio, A.; Triulzi, F.; Sironi, S.; Fazio, F. 1984: Prospects of a correlation between computerized magnetic resonance tomography, x-ray transmission computerized tomography and nuclear medicine. La Radiologia Medica 70(10): 767-775

Znamenácek, K. 1970: Prospects of a drainage bed for newborns immediately following birth. Ceskoslovenska Pediatrie 25(10): 497-498

Pratesi, F.; Caramelli, L. 1970: Prospects of a new nosological entity: non-arteriosclerotic diabetic arteriopathy. Bollettino Della Societa Italiana di Cardiologia 15(6): 481-483

Zarzycka, M. 1981: Prospects of activities of the section on blindness prevention: leading lecture. Klinika Oczna 83(7-8): 325-326

Fasanaro, G.; Gentile, A.; Stella, L. 1972: Prospects of an immunologic therapy of multiple sclerosis. Acta Neurologica 27(4): 367-378

Maserati, R.; Pesando, P.; Filice, C.; Guaschino, S.; Suter, F.; Tagliabue, R. 1982: Prospects of antibiotic prophylaxis in cesarean section. Giornale Italiano di Chemioterapia 29(1): 45-47

Tamai, K. 1981: Prospects of antibiotic treatment in dental and orosurgical field. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 98-102

Kobayashi, Y.; Haruta, T. 1981: Prospects of antibiotic treatment in pediatric field. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 72-79

Sugita, R. 1981: Prospects of antibiotic treatment in the field of otorhinolaryngology, with special reference to chronic otitis media. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 80-84

Ishibiki, K. 1981: Prospects of antibiotic treatment in the surgical field. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(1): 66-71

Pastina, R.; Varagnolo, C. 1967: Prospects of antiblastic chemotherapy in the treatment of autochthonous trophoblastic tumors. (Description of 2 clinical cases). Attualita di Ostetricia e Ginecologia 12(4): 337-353

Klener, P. 1980: Prospects of antitumour chemotherapy. Casopis Lekaru Ceskych 119(33-34): 881-884

Dutreix, J. 1972: Prospects of application of fast particles. Annales de Radiologie 15(1): 113-129

Ikehara, M.; Uemura, H. 1982: Prospects of application of genetic engineering to pharmaceutical industry. Nihon Rinsho. Japanese Journal of Clinical Medicine 40(8): 1700-1705

Salardi, C. 1966: Prospects of assistance in the domiciliary service for the aged. Giornale di Gerontologia. Supplemento 35: 111-124

Smolek, A. 1966: Prospects of automation in the administration of health services. I. Trends abroad and the situation at home. Ceskoslovenske Zdravotnictvi 14(4): 204-209

Ciaccia, A.; Pusinanti, F. 1967: Prospects of cardiac diagnosis in dispensary environments. Lotta Contro la Tubercolosi 37(4): 288-307

Houstĕk, J.; Vávrová, V. 1967: Prospects of children with mucoviscidosis. Ceskoslovenska Pediatrie 22(5): 458-466

Zherbin, E.A.; Shutko, A.N. 1984: Prospects of clinical radiobiology. Voprosy Onkologii 30(6): 25-32

Dargent, M. 1971: Prospects of clinical therapy of tumors. Minerva Medica 62(28): 1496-1502

Zhao, G.; Tong, T. 1995: Prospects of clinical uses of peptide growth factors. Zhonghua Yi Xue Za Zhi 75(6): 375-377

Casolo, P.; Monni, S. 1983: Prospects of combined drug therapy and surgery in hydatidosis. Minerva Chirurgica 38(19): 1385-1389

Wizenberg, M.J. 1981: Prospects of computed tomography in radiation therapy. Journal of Computed Tomography 5(3): 283-287

Kim, S.I. 1984: Prospects of continuing education for professional nurses during 1984. Taehan Kanho. Korean Nurse 23(1): 9

Lisker, R. 1974: Prospects of control of the hereditary diseases. Gaceta Medica de Mexico 107(4): 360-366

Dagaev, V.N.; Litvinov, N.N.; Kazachkov, V.I. 1995: Prospects of creation of a computerized advisory service for resuscitation physicians concerned with acute chemical poisoning in humans. Anesteziologiia i Reanimatologiia 1995(3): 45-47

Rychkov, R.S. 1982: Prospects of developing a microbiological industry in the light of the resolutions of the May (1982) Plenum of the Central Committee of the Communist Party of the SU. Mikrobiologiia 51(6): 889-895

Dobrev, I. 1973: Prospects of development of gastrointestinal surgery. Khirurgiia 26(3): 205-209

Josso, F. 1969: Prospects of development of information technics in blood transfusion. Bulletin de l'Institut National de la Sante et de la Recherche Medicale 24(3): 477-486

Spivak, F.I.; Shmaruk, L.G. 1965: Prospects of development of pharmacy in the Ukraine in the 1966-1970 period. Aptechnoe Delo 14(6): 7-10

Uglov, F.G.; Bogdan, T.T. 1973: Prospects of early diagnosis and treatment of lung cancer. Sovetskaia Meditsina 36(7): 13-18

Cashman, J.W. 1967: Prospects of federal programs. Bulletin of the new York Academy of Medicine 43(6): 472-478

Navrátil, K. 1974: Prospects of further cooperation between the physician and pharmacist. Ceskoslovenska Farmacie 23(4): 117-121

Freese, E. 1972: Prospects of gene therapy. Science 175(4025): 1024-1025

Koch, K.M. 1983: Prospects of hemofiltration. International Journal of Artificial Organs 6(1): 3-4

Perria, L.; Viale, G.L. 1972: Prospects of histochemical and biochemical research in cerebral oncology. Neuro-Chirurgie 18(2): 155-158

Debreczeni, L.H. 1965: Prospects of histochemical studies on the periodontium. Fogorvosi Szemle 58(12): 367-370

Rauss, K. 1968: Prospects of immunization against dysentery. Orvosi Hetilap 109(3): 113-117

Vagner, R.I.; Shutkin, V.A.; Barchuk, A.S. 1982: Prospects of improving the early diagnosis of lung cancer in women. Voprosy Onkologii 28(4): 72-76

Scrocca, P. 1969: Prospects of integration of the services of antituberculosis societies with the social disease sector. Lotta Contro la Tubercolosi 39(4): 272-275

Angelino, P.F.; Ferro, G.F.; Sturlese, U. 1968: Prospects of intensive therapy in the prognosis of myocardial infarct, with presentation of personal case statistics. Minerva Medica 59(103): 5795-5799

Marsiletti, G.C.; De Salvia, D.; Varagnolo, C. 1970: Prospects of interstitial radioisotopotherapy with P32 and Ir192 in radiosurgical therapeutic association in advanced cervix carcinoma. Minerva Ginecologica 22(3): 154-155

Emanuél', N.M. 1965: Prospects of kynetic study of biochemical processes in rational chemotherapy of cancer. Vestnik Akademii Meditsinskikh Nauk SSSR 20(8): 86-94

Ottani, G.; Mingarelli, G. 1967: Prospects of linear programming applied to the biomedical field. Minerva Medica 58(13): 491-497

Pichlmaier, H. 1969: Prospects of liver transplantation. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 75: 113-118

Baroian, O.V.; Zhdanov, V.M.; Solov'ev, V.D.; Zakstel'skaia, L.I.; Rvachev, L.V. 1972: Prospects of machine modelling of influenza epidemics for the territory of the USSR. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(5): 3-11

Divakov; Perunov 1965: Prospects of meat transportation. Veterinariia 42(7): 101

Kováts, F. 1972: Prospects of morphometry in respiratory physiopathology. Les Bronches 22(5): 282-298

Sculier, J.P.; Klastersky, J. 1982: Prospects of new chemotherapies. Revue Medicale de Bruxelles 3(8): 519-527

Ha, U.S. 1983: Prospects of nurses' status in the future. Taehan Kanho. Korean Nurse 22(3): 74-82

Weill, R. 1965: Prospects of odontologic research. Revue Francaise d'Odonto-Stomatologie 12(9): 1441-1444

Trivellini, A. 1968: Prospects of organ transplantation. Archivio Italiano di Chirurgia 94(2): 307-308

Busuoli, G. 1968: Prospects of personal dosimetry of fast neutrons. Minerva Fisiconucleare 12(2): 55-58

Oberhofer, M. 1968: Prospects of personal dosimetry of x and gamma rays: comparison between radiophoto-luminescent dosimetry and film dosimetry. Minerva Fisiconucleare 12(2): 51-54

Fava, G. 1968: Prospects of personal dosimetry of x-rays and gamma-rays (powder and film). Minerva Fisiconucleare 12(2): 55

Buriánek, J.; Stáhlavská, A. 1972: Prospects of pharmaceutical analysis. Ceskoslovenska Farmacie 21(1): 3-6

Romagnani, S. 1969: Prospects of preparation of a vaccine against group a Streptococcus. Folia Allergologica 16(5): 443-448

Marcello, D. 1970: Prospects of psychiatric sectiorial assistance in the province of Catanzaro. L'Ospedale Psichiatrico 38(3): 422-436

Guensberger, E.; Pogády, J. 1971: Prospects of psychopathology. Ceskoslovenska Psychiatrie 67(3): 157-163

Flora, G.; Hilbe, G. 1968: Prospects of reconstructive vascular surgery in chronic arterial obliteration of the extremities in geriatrics. Der Landarzt 44(26): 1245-1248

Goss, R.J. 1980: Prospects of regeneration in man. Clinical Orthopaedics and Related Research 151: 270-282

Sundquist, H. 1983: Prospects of research and development in the Finnish medical industry. Duodecim; Laaketieteellinen Aikakauskirja 99(13): 821-824

Daĭniak, L.B. 1968: Prospects of research development and methods of treatment of allergic diseases of otolaryngological organs. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 28(5): 20-28

Snaid, V. 1971: Prospects of research in degenerative cystic pathology of the ovary. Ceskoslovenska Gynekologie 36(1): 12-14

Veselý, K. 1971: Prospects of research in pediatric gynecology. Ceskoslovenska Gynekologie 36(1): 6-7

Felder, E. 1970: Prospects of research in the field of contrast media. La Radiologia Medica 56(9): 844-851

Allegra, L.; Monastero, A.; Gioia, V. 1967: Prospects of research on the behavior of endoalvlar surface tension ar aerosol administration of pharmacological substances. Minerva Medica 58(98): 4392-4401

Tarro, G. 1980: Prospects of respiratory syncytial virus vaccines. Annali Sclavo; Rivista di Microbiologia E di Immunologia 22(1): 40-41

Khudoley, V.V.; Pliss, G.B. 1984: Prospects of short-term tests in primary cancer prevention. Neoplasma 31(4): 475-478

Ferrazzi, D.; Filippini, C. 1968: Prospects of sociotherapy in the field of psychiatric care of aged mental patients. Rassegna di Neuropsichiatria e Scienze Affini 22(3): 356-362

Zwinger, A. 1971: Prospects of solution of problems of fetal damage during pregnancy. Ceskoslovenska Gynekologie 36(1): 14-16

Karpov, N.A. 1970: Prospects of studying maiignant tumors of the upper respiratory tract and their geographic distribution. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 30(3): 8-11

Hefti, A. 1981: Prospects of success with the papillary bleeding index for the motivation of children with pronounced gingivitis. Schweizerische Monatsschrift für Zahnheilkunde 91(11): 963-968

Kremer, K.; Berghaus, H.; Düwell, J.; Filthaut, W. 1967: Prospects of successful radical surgery in the so-called peripapillary carcinomas. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 38(6): 278-284

Repin, I.M. 1981: Prospects of surgical treatment in fibrous-cavernous pulmonary tuberculosis. Problemy Tuberkuleza 3: 23-27

Hartlapp, J.H.; Illiger, H.J. 1983: Prospects of systemic drug treatment in metastasized bladder and kidney tumors. Mmw Munchener Medizinische Wochenschrift 125(9): 172-175

Raĭkhlin, N.T.; Bukhvalov, I.B. 1973: Prospects of the Gomori lead method in the electron microscopic histochemistry of ATPase. Arkhiv Anatomii Gistologii i Embriologii 65(12): 109-118

Silvestrini, B. 1966: Prospects of the Italian pharmaceutical industry in the light of American experience. Bollettino Chimico Farmaceutico 105(7): 477-480

Vecchietti, G.; Onnis, A. 1970: Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences). Minerva Ginecologica 22(9): 459-462

Diurich, V.M.; Kulakova, T.V. 1972: Prospects of the development of specialized care of children in the RSFSR. Voprosy Okhrany Materinstva i Detstva 17(3): 3-7

Bessonov, A.S. 1974: Prospects of the eradication of some helminthozoonoses in the USSR in connection with changes in the technology of animal husbandry. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 43(6): 676-679

Konttinen, Y. 1972: Prospects of the future of mankind and of the medical profession. Duodecim; Laaketieteellinen Aikakauskirja 88(4): 323-326

Rayner, H.; Siebert, H.; Schorr, R.; Winter, K. 1970: Prospects of the health care for children and youth. a rejoinder. Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 16(8): 646-648

Velican, C. 1965: Prospects of the histochemical study of the gastric mucosa correlated with the problem of gastritis. Medicina Interna 17(9): 1055-1062

Vaur, J.L. 1984: Prospects of the patient with a colectomy. L'Infirmiere Francaise 252: 17-21

Bógush, L. 1966: Prospects of the surgery of pulmonary tuberculosis. El Torax 15(2): 81-84

Terzin, A.L. 1965: Prospects of the treatment of viral infections. Medicinski Pregled 18(9): 379-392

Verlato, R.; Cessi, C.; Tajoli, E.; Signorini, G.P.; Rizzi, R. 1965: Prospects of the use in anesthesiological emergency of electrocardiotherapy with a defibrillator with self-inductance. 3. Acta Anaesthesiologica 16(Suppl 4): 167-171

Tacu, V. 1980: Prospects of the use of beta-blocking agents in treatment of myocardial infarct. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 84(3): 407-414

Nasonov, E.L.; Shtutman, V.Z.; Nasonova, V.A. 1994: Prospects of the use of cyclosporin a in rheumatic diseases. Klinicheskaia Meditsina 72(5): 12-19

Horejsí, J. 1973: Prospects of the use of diverse molecular biological studies in the medical practice. Casopis Lekaru Ceskych 112(4): 97-101

Zheltakov, M.M.; Vinokurov, I.N. 1966: Prospects of the use of preparations of the psoralen group in the treatment of vitiligo patients. Sovetskaia Meditsina 29(8): 110-115

Purini, T. 1966: Prospects of the use of rheographic examinations of patients with head injuries. Minerva Anestesiologica 32(9): 484-485

Mariani, B. 1970: Prospects of the use of the anti-tuberculosis vaccination with SDV (Salvioli's diffusing vaccine) in the current epidemiologic phase of tuberculosis. La Clinica Pediatrica 52(6): 275-279

Terzi, I. 1971: Prospects of the use of transfusion aids in the organization of first-aid services on board ships. Annali di Medicina Navale 76(1): 95-102

Xu, H. 1995: Prospects of toxicology in preventive medicine in China. Zhonghua Yu Fang Yi Xue Za Zhi 29(1): 4-5

Tsyganov, A.I. 1967: Prospects of treatment of subjective aural noises by ganglionic blockaders. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 27(1): 39-43

Milonov, O.B.; Plotkina, N.S. 1970: Prospects of using antimicrobaal materials in surgical practice. Khirurgiia 46(4): 117-121

Nikolaev, M.P.; Konstantinova, Z.D.; Mertsalova, O.N.; Sheremet, A.S. 1980: Prospects of using cavinton for treating Ménière's disease. Vestnik Otorinolaringologii 3: 18-22

Smirnov, I.G. 1973: Prospects of using compression-distraction apparatus in the staged treatment of wounded with fractures of the bones of the extremities. Voenno-Meditsinskii Zhurnal 10: 28-31

Kaz'min, A.I.; Belen'kiĭ, V.E.; Savel'ev, L.A. 1984: Prospects of using diagnostic biomechanical equipment. Ortopediia Travmatologiia i Protezirovanie 11: 70-73

Lukich, V.L.; Matrenitskaia, N.A.; Zavodnov, V.I.; Vasil'eva, O.V.; Kuzin, N.M. 1984: Prospects of using hyperbaric oxygenation in treating peptic ulcer. Terapevticheskii Arkhiv 56(2): 49-51

Chelidze, L.N.; Zhgenti, T.G.; Chichua, M.T. 1980: Prospects of using magnetotherapy in stomatology. Stomatologiia 59(5): 76-80

Sviridov, N.K. 1981: Prospects of using modern x-ray contrast substances for intravenous cholegraphy (a review of the literature). Vestnik Rentgenologii i Radiologii 1981(6): 78-81

Zhogolev, K.D.; Stoianova, N.A. 1983: Prospects of using the immunoadhesive hemagglutination reaction for leptospirosis diagnosis. Trudy Instituta Imeni Pastera 60: 119-123

Kabanov, A.N.; Sitko, L.A.; Loshchilov, V.I.; Mozgovoĭ, I.V.; Pedder, V.V. 1983: Prospects of using ultrasonic instruments in endobronchial surgery. Grudnaia Khirurgiia 1: 50-53

Khomenok, V.P.; Medvedovskiĭ, V.G. 1973: Prospects of using whole-body fluorography in forensic medicine. Voenno-Meditsinskii Zhurnal 4: 76-77

Matile, P. 1969: Prospects of yeast cytology. Antonie van Leeuwenhoek 35(Suppl): 59-70

Chassagne, D.; Dutreix, A.; Attaia, A.B.; Rosenwald, J.C.; Pierquin, B. 1970: Prospects offered by a computer program on calculating dosage in gynecologic curietherapy. Journal de Radiologie d'Electrologie et de Medecine Nucleaire 51(11): 647-650

MacGregor, C.; Karchmer, S. 1971: Prospects offered by the amniotic fluid in evaluation of the fetal status. Ginecologia y Obstetricia de Mexico 30(181): 491-501

Hanyu, M. 1983: Prospects on public health nursing activities toward the end of the century. Japanese Journal for Public Health Nurse 39(10): 818-822

Funakubo, H. 1982: Prospects on the introduction of robots in the medical field. Iyo Denshi to Seitai Kogaku. Japanese Journal of Medical Electronics and Biological Engineering 20(6): 451-454

Antoine, B. 1970: Prospects on the quality and the number of physicians in France. La Presse Medicale 78(34): 1521-1522

Poussier, P.; Reach, G.; Marre, M.; Assan, R. 1981: Prospects opened by the insulin pump. La Nouvelle Presse Medicale 10(17): 1377-1379

Stamler, J.; Berkson, D.M. 1972: Prospects with multifactorial approaches emphasizing improvement in life style. Advances in Experimental Medicine and Biology 26(0): 213-244

Franco, L. 1967: Prospects, modern trends and advances in the therapy of tumors. Archivio Per le Scienze Mediche 123(5): 236-246

Frei, E. 1972: Prospectus for cancer chemotherapy. Cancer 30(6): 1656-1661

Weinerman, E.R. 1967: Prospectus for medical care--twenty-first centrury. Connecticut Medicine 31(7): 499-503

McDonald, T.P. 1981: Assay and site of production of thrombopoietin. British Journal of Haematology 49(4): 493-499

Götze, A.; Menière, P. 1970: Prosper Menière 1799-1862. Orvosi Hetilap 111(23): 1350

Pappas, D.G.; Galanos, A.N.; Méniere, P. 1982: Prosper Méniere: beyond the controversial autopsy report. Southern Medical Journal 75(4): 470-472

Rhode, N. 1993: Prospering through professionalism. Journal of the California Dental Association 21(10): 23-25

Peck, S.; Peck, H. 1980: Prosperity and decay: a portrait of the Dutch golden age. Dental Abstracts; a Selection of World Dental Literature 25(3): 116-118

Huebschmann, H. 1966: Prosperity and disease. Prensa Medica Argentina 53(1): 519-521

Merkus, J.W. 1984: Prosperity diseases of current times. Tijdschrift Voor Ziekenverpleging 37(18): 563-564

Hedri, A. 1971: Prosperity matrimonial crises. Zeitschrift für Psychotherapie und Medizinische Psychologie 21(1): 35-38

Lange, K.; Treser, G.; Ty, A.; Wasserman, E. 1965: The histologic and immunologic features of acute, subacute and chronic glomerulonephritis. Transactions of the Association of American Physicians 78(1): 117-134

Pintér, E. 1969: Prosperous refugees. a social psychiatric study of Hungarian refugees in Switzerland. Bibliotheca Psychiatrica et Neurologica 138: Suppl 138: 1+

Müller, E. 1967: Prosperous society and addiction hazards. Medizinische Klinik 62(10): 391-392

Popkema, B. 1966: Prosperous--not clean. Tijdschrift Voor Ziekenverpleging 19(7): 224-233

Gröhn, P.; Heinonen, E.; Appelqvist, P.; Hajba, A.; Holopainen, E.; Paavolainen, M.; Palva, T. 1984: Prospidin chemotherapy in recurrent head and neck carcinoma: a phase Ii study. Cancer Treatment Reports 68(6): 915-917

El'kin, V.D.; Datskovskiĭ, S.B.; Rudakova, R.A. 1982: Prospidin cream in the treatment of pointed condylomata acuminata. Urologiia i Nefrologiia 4: 62-63

Khvatova, A.V.; Mikheev, V.L.; Vaĭnshteĭn, E.S.; Chernov, V.A.; Itsikson, L.I. 1974: Prospidin in the complex treatment of retinoblastomas. Vestnik Oftalmologii 2: 82-84

Razzhivin, A.I. 1969: Prospidin in the treatment of cancer of the larynx. Vestnik Otorinolaringologii 31(3): 42-45

Sneddon, I.B. 1984: Prosser-White oration. then and now. Clinical and Experimental Dermatology 9(1): 3-17

Ciko, Z. 1980: Prostacyclin (PGi 2)--an effective antithrombotic. Vojnosanitetski Pregled 37(3): 190-192

Davies, S.C.; Machin, S.J. 1983: Prostacyclin (PGI2). Intensive Care Medicine 9(2): 49-52

Seyfried, H.; Sinzinger, H.; Silberbauer, K. 1980: Prostacyclin (PGI2) activity in the rectal mucosa of patients with ulcerative colitis. Wiener Klinische Wochenschrift 92(8): 282-284

Sterin-Borda, L.; Gimeno, M.; Borda, E.; del Castillo, E.; Gimeno, A.L. 1981: Prostacyclin (PGI2) and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis. Prostaglandins 22(2): 267-278

Esquivel, C.O.; Björck, C.G.; Saldeen, P.; Ljungnér, H.; Bergqvist, D. 1984: Prostacyclin (PGI2) and plasminogen activator (PA) activity in umbilical vein grafts. An experimental study. Acta Chirurgica Scandinavica 150(3): 211-216

Sinzinger, H.; Fitscha, P. 1984: Prostacyclin (PGI2) contracts normal and varicose human saphenous veins. Vasa. Zeitschrift für Gefasskrankheiten 13(3): 228-230

Omini, C.; Brunelli, G.; Folco, G.C.; Marini, A.; Pasargiklian, R.; Berti, F. 1981: Prostacyclin (PGI2) generation in lungs of fetal and newborn rabbit. Prostaglandins 21(2): 345-351

Bussolino, F.; Tetta, C.; Masera, C.; Antro, C.; Camussi, G.; Ragni, R. 1982: Prostacyclin (PGI2) inhibits neutropenia induced by immune complexes. Minerva Nefrologica 29(2): 116-117

Ehrman, M.L.; Jaffe, E.A. 1980: Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity. Prostaglandins 20(6): 1103-1116

Chuang, H.Y.; Mohammad, S.F.; Mason, R.G. 1980: Prostacyclin (PGI2) inhibits the enhancement of granulocyte adhesion to Cuprophane induced by immunoglobulin G. Thrombosis Research 19(1-2): 1-9

Roberts, A.M.; Messina, E.J.; Kaley, G. 1981: Prostacyclin (PGI2) mediates hypoxic relaxation of bovine coronary arterial strips. Prostaglandins 21(4): 555-569

Dusting, G.J.; Mullins, E.M.; Nolan, R.D. 1981: Prostacyclin (PGI2) release accompanying angiotensin conversion in rat mesenteric vasculature. European Journal of Pharmacology 70(2): 129-137

Dlugosz, J.; Gabryelewicz, A.; Andrzejewska, A.; Triebling, A.; Brzozowski, J.; Wereszczynska, U. 1982: Prostacyclin (PGI2) stabilises hepatic lysosomes during acute experimental pancreatitis in dogs. Zeitschrift für Experimentelle Chirurgie 15(4): 210-218

Morera, S.; Santoro, F.M.; Rosón, M.I.; de la Riva, I.J. 1983: Prostacyclin (PGI2) synthesis in the vascular wall of rats with bilateral renal artery stenosis. Hypertension 5(6 Part 3): V38-V42

Sinzinger, H.; Feigl, W.; Silberbauer, K.; Oppolzer, R.; Winter, M.; Auerswald, W. 1980: Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesions. Experimentelle Pathologie 18(3): 175-180

Feldman, R. 1980: Prostacyclin (PGX, PGI2)-vascular anti-aggregation hormone regulating hemostasis. Polskie Archiwum Medycyny Wewnetrznej 64(1): 57-67

Seelig, R.F.; Kerr, J.C.; Hobson, R.W.; Machiedo, G.W. 1981: Prostacyclin (epoprostenol): its effect on canine splanchnic blood flow during hemorrhagic shock. Archives of Surgery 116(4): 428-430

Breuer, C.; Abri, O. 1995: Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease--is quantification of the therapeutic effect possible with tcPO2 measurements?. VASA. Zeitschrift für Gefasskrankheiten 24(1): 62-71

Seto, D.S.; Matsuo, M.; Hokama, J.L.; Shirai, L.K.; Hokama, Y. 1983: Prostacyclin (prostaglandin I2) formation in lung tissues of infants in sudden infant death syndrome (SIDS), non-SIDS and adults. Journal of Medicine 14(5-6): 451-459

Bodzenta, A.; Thomson, J.M.; Poller, L. 1980: Prostacyclin activity in amniotic fluid in pre-eclampsia. Lancet 2(8195 Part 1): 650

Longmore, D.B.; Bennett, J.G.; Hoyle, P.M.; Smith, M.A.; Gregory, A.; Osivand, T.; Jones, W.A. 1981: Prostacyclin administration during cardiopulmonary bypass in man. Lancet 1(8224): 800-804

Orekhov, A.N.; Tertov, V.V.; Smirnov, V.N. 1983: Prostacyclin analogues as antiatherosclerotic drugs. Lancet 2(8348): 521

Brox, J.H.; Nordøy, A. 1982: Prostacyclin and 51Cr release in cultured human endothelial cells. Haemostasis 12(4): 345-352

Bálint, G.A.; Varró, V. 1984: Prostacyclin and DNA-synthesis inhibitors: their interaction on experimental gastric ulcer in the rat. Acta Medica Hungarica 41(4): 259-261

Adler, B.; Gimbrone, M.A.; Schafer, A.I.; Handin, R.I. 1981: Prostacyclin and beta-adrenergic catecholamines inhibit arachidonate release and PGI2 synthesis by vascular endothelium. Blood 58(3): 514-517

Paul, K.S.; Whalley, E.T.; Forster, C.; Lye, R.; Dutton, J. 1982: Prostacyclin and cerebral vessel relaxation. Journal of Neurosurgery 57(3): 334-340

Weston, M.J. 1983: Prostacyclin and extracorporeal circulation. British Medical Bulletin 39(3): 285-288

Jørgensen, K.A.; Møller-Petersen, J.; Ekelund, S.; Pedersen, R.S. 1981: Prostacyclin and haemolytic, thrombocytopenic microangiopathy. Lancet 2(8245): 530

Whittle, B.J.; Moncada, S. 1984: Prostacyclin and its analogues for the therapy of thromboembolic disorders. Advances in Experimental Medicine and Biology 164: 193-209

Liggins, G.C.; Skinner, S.J.; Lubbe, W.F. 1984: Prostacyclin and maternal lupus anticoagulant. Lancet 1(8369): 170

Mehta, P.; Albiol, L. 1982: Prostacyclin and platelet aggregation in sickle cell disease. Pediatrics 70(3): 354-359

Carreras, L.O.; Defreyn, G.; van Houtte, E.; Vermylen, J.; van Assche, A. 1981: Prostacyclin and pre-eclampsia. Lancet 1(8217): 442

Watkins, W.D.; Peterson, M.B.; Crone, R.K.; Shannon, D.C.; Levine, L. 1980: Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension. Lancet 1(8177): 1083

Susić, H.; Malik, K.U. 1981: Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog. Journal of Pharmacology and Experimental Therapeutics 218(3): 588-592

Gecse, A.; Ottlecz, A.; Mezei, Z.; Telegdy, G.; Joó, F.; Dux, E.; Karnushina, I. 1982: Prostacyclin and prostaglandin synthesis in isolated brain capillaries. Prostaglandins 23(3): 287-297

Perico, N.; Schieppati, A.; Mecca, G.; Rossi, E.C.; Remuzzi, G. 1982: Prostacyclin and renal diseases. Clinical Nephrology 18(3): 111-119

Nijkamp, F.P. 1982: Prostacyclin and the cardiovascular system. Netherlands Journal of Medicine 25(1): 15-21

Szczeklik, A.; Kopec, M.; Sladek, K.; Musial, J.; Chmielewska, J.; Teisseyre, E.; Dudek-Wojciechowska, G.; Palester-Chlebowczyk, M. 1983: Prostacyclin and the fibrinolytic system in ischemic vascular disease. Thrombosis Research 29(6): 655-660

Anonymous 1982: Prostacyclin and thromboxane A. British Medical Journal 284(6313): 418-421

Williams, G.A.; Reeser, F.; O'Brien, W.J.; Fleischman, J.A. 1983: Prostacyclin and thromboxane A2 derivatives in rhegmatogenous subretinal fluid. Archives of Ophthalmology 101(3): 463-464

Serneri, G.G.; Masotti, G.; Gensini, G.F.; Poggesi, L.; Abbate, R.; Mannelli, M. 1981: Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation?. Cardiovascular Research 15(5): 287-295

Lee, S.H.; Wainscoat, J.S.; Zeitlin, H.; Bolton, F.G.; Leaver, H.A.; Seawright, A.; Preece, J.M. 1981: Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura. British Medical Journal 283(6303): 1351-1352

Korbut, R.; Boyd, J.; Eling, T. 1982: Prostacyclin and thromboxane A2 release in isolated rat lungs. Prostaglandins 23(1): 67-75

Salzman, P.M.; Salmon, J.A.; Moncada, S. 1980: Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery. Journal of Pharmacology and Experimental Therapeutics 215(1): 240-247

Yabuno, N. 1984: Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm. Acta Medica Okayama 38(3): 239-250

Yabuno, N. 1984: Prostacyclin and thromboxane in cerebral vasospasm: effects of prostacyclin on experimentally-induced cerebral vasospasm. Acta Medica Okayama 38(2): 147-158

Ylikorkala, O.; Huttunen, K.; Järvi, J.; Viinikka, L. 1982: Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis. Clinical Nephrology 18(2): 83-87

Kaar, M.L.; Kaapa, P.; Viinikka, L.; Ylikorkala, O. 1983: Prostacyclin and thromboxane in diabetic children. Prostaglandins Leukotrienes and Medicine 11(3): 339-344

Johnston, C.; Carey, F.; Forder, R.A.; Haworth, D. 1984: Prostacyclin and thromboxane in non-insulin dependent diabetes: the chlorpropamide alcohol flush reaction revisited. Clinical Science 67(6): 633-638

Viinikka, L. 1981: Prostacyclin and thromboxane in thrombosing atherosclerotic diseases. Duodecim; Laaketieteellinen Aikakauskirja 97(13): 925-927

Williams, G.A.; Reeser, F.H. 1983: Prostacyclin and thromboxane levels. Ophthalmology 90(7): 856-857

Tissot, M.; Bonne, C.; Martin, B.; Solier, M.; Giroud, J.P. 1984: Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat. Agents and Actions 14(1): 76-81

Honn, K.V.; Busse, W.D.; Sloane, B.F. 1983: Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. Biochemical Pharmacology 32(1): 1-11

Leithner, C.; Sinzinger, H.; Silberbauer, K. 1980: Prostacyclin as a protective factor for blood vessels. Fortschritte der Medizin 98(47-48): 1845-1849

Das, U.N. 1983: Prostacyclin as an endogenous anti-arrhythmic agent. Basic Research in Cardiology 78(6): 716-718

Hory, B.; Saint-Hillier, Y.; Perol, J.C. 1983: Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis. Nephron 33(1): 71

Chelly, J.E. 1981: Prostacyclin as vasodilator in anaesthesia and intensive care. Lancet 2(8239): 198

Brotherton, A.F.; Hoak, J.C. 1983: Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase. Journal of Clinical Investigation 72(4): 1255-1261

Brotherton, A.F.; Macfarlane, D.E.; Hoak, J.C. 1982: Prostacyclin biosynthesis in vascular endothelium is not inhibited by cyclic AMP. Studies with 3-isobutyl-1-methylxanthine and forskolin. Thrombosis Research 28(5): 637-647

Chiavarelli, M.; Moncada, S.; Mullane, K.M. 1982: Prostacyclin can either increase or decrease heart rate depending on the basal state. British Journal of Pharmacology 75(1): 243-249

Banai, J.; Rózsa, I.; Tihanyi, K.; Szántó, I. 1984: Prostacyclin content of jejunal mucosa in non-operated patients and after Billroth Ii gastrectomy. Prostaglandins Leukotrienes and Medicine 16(2): 253-254

Webster, J.; Rees, A.J.; Lewis, P.J.; Hensby, C.N. 1980: Prostacyclin deficiency in haemolytic-uraemic syndrome. British Medical Journal 281(6235): 271

Remuzzi, G.; Imberti, L.; de Gaetano, G. 1981: Prostacyclin deficiency in thrombotic microangiopathy. Lancet 2(8260-61): 1422-1423

Triulzi, M.O.; Clement, M.G.; Celsi, A.; Aguggini, G. 1981: Prostacyclin effect on blood pressure in pig with aortic obstruction. Prostaglandins and Medicine 7(4): 281-291

Triulzi, M.O.; Cirino, D.; Gentile, F.; Balice, G.; Aguggini, G.; Maggi, G.C. 1981: Prostacyclin effect on cardiovascular system in man evaluated by echocardiography. Prostaglandins and Medicine 7(6): 501-510

Triulzi, M.O.; Sansonetti, G.; Signorini, G.; Mattioli, R.; Maggi, G.C.; Aguggini, G. 1983: Prostacyclin effect on heart rate in the pig. Prostaglandins Leukotrienes and Medicine 10(3): 269-278

Woods, H.F.; Weston, M.J.; Bunting, S.; Moncada, S.; Vane, J. 1980: Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption. Artificial Organs 4(3): 176-179

Szczeklik, A.; Szczeklik, J.; Nizankowski, R.; Głuszko, P. 1980: Prostacyclin for unstable angina. New England Journal of Medicine 303(15): 881

Sinzinger, H.; Silberbauer, K.; Auerswald, W. 1980: Prostacyclin formation by rat endothelial layer. Thrombosis and Haemostasis 43(3): 229

Hauben, D.J.; Zijlstra, F.J. 1984: Prostacyclin formation in delayed pig flank flaps. Annals of Plastic Surgery 13(4): 304-308

Gisinger, C.; Sinzinger, H.; Ferlitsch, A.; Seyfried, H.; Feigl, W. 1981: Prostacyclin formation in human cancer tissue of the gastrointestinal tract. Wiener Klinische Wochenschrift 93(23): 717-720

Shelton, J.D. 1982: Prostacyclin from the uterus and woman's cardiovascular advantage. Prostaglandins Leukotrienes and Medicine 8(5): 459-466

Remuzzi, G.; Mecca, G.; Livio, M.; de Gaetano, G.; Donati, M.B.; Pearson, J.D.; Gordon, J.L. 1980: Prostacyclin generation by cultured endothelial cells in haemolytic uraemic syndrome. Lancet 1(8169): 656-657

Gullner, H.G.; Nicolaou, K.C.; Bartter, F.C. 1980: Prostacyclin has effects on proximal and distal tubular function in the dog. Prostaglandins and Medicine 4(3): 141-146

Heinrich, D.; Schleussner, E.; Wagner, W.L.; Sellmann-Richter, R.; Hehrlein, F.W. 1983: Prostacyclin in aortocoronary bypass surgery: a double-blind, placebo-controlled study. Thrombosis Research 32(4): 409-426

Faichney, A.; Davidson, K.G.; Wheatley, D.J.; Davidson, J.F.; Walker, I.D. 1982: Prostacyclin in cardiopulmonary bypass operations. Journal of Thoracic and Cardiovascular Surgery 84(4): 601-608

Zygulska-Mach, H.; Kostka-Trabka, E.; Nitoń, A.; Gryglewski, R.J. 1980: Prostacyclin in central retinal vein occlusion. Lancet 2(8203): 1075

Ylikorkala, O.; Mäkilä, U.M.; Viinikka, L. 1983: Prostacyclin in complicated pregnancies. American Journal of Obstetrics and Gynecology 147(6): 728-729

Ribeiro, L.G.; Brandon, T.A.; Hopkins, D.G.; Reduto, L.A.; Taylor, A.A.; Miller, R.R. 1981: Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality. American Journal of Cardiology 47(4): 835-840

Steinberg, S.M.; Dehring, D.J.; Gower, W.R.; Vento, J.M.; Lowery, B.D.; Cloutier, C.T. 1983: Prostacyclin in experimental septic acute respiratory failure. Journal of Surgical Research 34(4): 298-302

Turney, J.H.; Dodd, N.J.; Weston, M.J. 1981: Prostacyclin in extracorporeal circulations. Lancet 1(8229): 1101

Weston, M.J. 1983: Prostacyclin in haemodialysis and charcoal haemoperfusion. Contributions to Nephrology 36: 68-72

Addonizio, V.P.; Fisher, C.A.; Bowen, J.C.; Palatianos, G.C.; Colman, R.W.; Edmunds, L.H. 1981: Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation. Transactions - American Society for Artificial Internal Organs 27: 304-307

Vane, J.R.; Bunting, S.; Moncada, S. 1982: Prostacyclin in physiology and pathophysiology. International Review of Experimental Pathology 23: 161-207

Spitz, B.; Deckmyn, H.; Van Assche, F.A.; Vermylen, J. 1984: Prostacyclin in pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology 18(5-6): 303-308

Moncada, S.; Vane, J.R. 1980: Prostacyclin in the cardiovascular system. Advances in Prostaglandin and Thromboxane Research 6: 43-60

Szczeklik, A.; Gryglewski, R.J.; Nizankowski, R.; Szczeklik, J.; Skawiński, S.; Głuszko, P. 1980: Prostacyclin in the therapy of peripheral arterial disease. Advances in Prostaglandin and Thromboxane Research 7: 687-689

Gryglewski, R.J.; Szczeklik, A. 1984: Prostacyclin in the treatment of atherosclerosis obliterans and other vascular diseases. Advances in Experimental Medicine and Biology 164: 211-213

Gryglewski, R.J.; Szczeklik, A. 1984: Prostacyclin in vascular pathology--therapeutic possibilities. Annals of Clinical Research 16(5-6): 253-261

Kirby, J.D.; Lima, D.R.; Dowd, P.M.; Kilfeather, S.; Turner, P. 1980: Prostacyclin increases cyclic-nucleotide responsiveness of lymphocytes from patients with systemic sclerosis. Lancet 2(8192): 453-454

Gimeno, A.L.; Chaud, M.; Bonacossa, A.; Franchi, A.M.; Gimeno, M.F. 1983: Prostacyclin induces a surprising long-lasting motility in quiescent uterine strips (indomethacin-treated) isolated from ovariectomized rats. Prostaglandins 26(4): 663-676

Rådegran, K.; Papaconstantinou, C. 1980: Prostacyclin infusion during cardiopulmonary bypass in man. Thrombosis Research 19(1-2): 267-270

Rådegran, K.; Arén, C.; Teger-Nilsson, A.C. 1982: Prostacyclin infusion during extracorporeal circulation foe coronary bypass. Journal of Thoracic and Cardiovascular Surgery 83(2): 205-211

Beattie, T.J.; Murphy, A.V.; Willoughby, M.L.; Belch, J.J. 1981: Prostacyclin infusion in haemolytic-uraemic syndrome of children. British Medical Journal 283(6289): 470

Chaignon, M.; Ruffie, M.L.; Lucsko, M.; Cuche, J.L.; Guedon, J.; O'Grady, J. 1982: Prostacyclin infusion in hypertension: acute hemodynamic and hormonal effects. New England Journal of Medicine 307(9): 559

Edhag, O.; Henriksson, P.; Wennmalm, A. 1983: Prostacyclin infusion in patients with acute myocardial infarction (preliminary report). New England Journal of Medicine 308(17): 1032-1033

Jones, I.R.; Psaila, J.V. 1981: Prostacyclin inhibition and ulcerogenesis. Gastroenterology 81(3): 637

Lapetina, E.G. 1984: Prostacyclin inhibition of phosphatidic acid synthesis in human platelets is not mediated by protein kinase C. Biochemical and Biophysical Research Communications 120(1): 37-44

Aznavoorian, S.A.; Utsunomiya, T.; Krausz, M.M.; Cohn, L.H.; Shepro, D.; Hechtman, H.B. 1983: Prostacyclin inhibits 5-hydroxytryptamine release but stimulates thromboxane synthesis during cardiopulmonary bypass. Prostaglandins 25(4): 557-570

Ruwart, M.J.; Rush, B.D. 1984: Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs. Gastroenterology 87(2): 392-395

Mullane, K.M.; Moncada, S. 1980: Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment. European Journal of Pharmacology 66(4): 355-365

Fischer, S.; Scherer, B.; Weber, P.C. 1983: Prostacyclin metabolism in adults and neonates. Urinary profiles of 6-ketoprostaglandin F1 alpha and 2,3-dinor-6-ketoprostaglandin F1 alpha studied by gas chromatography-mass spectrometry. Biochimica et Biophysica Acta 750(1): 127-133

Hajjar, D.P.; Weksler, B.B.; Falcone, D.J.; Hefton, J.M.; Tack-Goldman, K.; Minick, C.R. 1982: Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. Journal of Clinical Investigation 70(3): 479-488

Mugridge, K.G.; Higgs, G.A.; Moncada, S. 1984: Prostacyclin modulates the responses to leukotrienes C4 and D4 of guinea-pig airway smooth muscle. European Journal of Pharmacology 104(1-2): 1-7

Parise, L.V.; Venton, D.L.; Le Breton, G.C. 1982: Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation. Thrombosis Research 28(6): 721-730

Turney, J.H.; Dodd, N.J.; Williams, L.C.; Weston, M.J. 1981: Prostacyclin prevents endothelial and platelet damage during dialysis. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 18: 111-116

Rösen, R.; Rösen, P.; Ohlendorf, R.; Schrör, K. 1981: Prostacyclin prevents ischemia-induced increase of lactate and cyclic AMP in ischemic myocardium. European Journal of Pharmacology 69(4): 489-491

Dusting, G.J.; Nolan, R.D.; Woodman, O.L.; Martin, T.J. 1983: Prostacyclin produced by the pericardium and its influence on coronary vascular tone. American Journal of Cardiology 52(2): 28A-35A

Gerber, J.G.; Payne, N.A.; Murphy, R.C.; Nies, A.S. 1981: Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. Journal of Clinical Investigation 67(3): 632-636

Voss, R.; ten Hoor, F.; Matthias, F.R. 1983: Prostacyclin production and atherosclerosis of the rabbit aorta. Advances in Prostaglandin Thromboxane and Leukotriene Research 11: 469-474

Reeves, J.T.; van Grondelle, A.; Voelkel, N.F.; Walker, B.; Lindenfeld, J.; Worthen, S.; Mathias, M. 1983: Prostacyclin production and lung endothelial cell shear stress. Progress in Clinical and Biological Research 136: 125-131

Olsson, A.G.; Carlson, L.A.; Anggard, E.; Ciabattoni, G. 1983: Prostacyclin production augmented in the short term by nicotinic acid. Lancet 2(8349): 565-566

Evans, C.E.; Billington, D.; McEvoy, F.A. 1984: Prostacyclin production by confluent and non-confluent human endothelial cells in culture. Prostaglandins Leukotrienes and Medicine 14(2): 255-266

Dejana, E.; Balconi, G.; De Castellarnau, C.; Barbieri, B.; Vergara-Dauden, M.; De Gaetano, G. 1983: Prostacyclin production by human endothelial and bovine smooth muscle cells in culture. Effect of repeated stimulation with arachidonic acid, thrombin and ionophore A23187. Biochimica et Biophysica Acta 750(2): 261-267

Jogee, M.; Myatt, L.; Moore, P.; Elder, M.G. 1983: Prostacyclin production by human placental cells in short-term culture. Placenta 4(3): 219-230

Axelrod, L.; Levine, L. 1981: Prostacyclin production by isolated adipocytes. Diabetes 30(2): 163-167

Petry, J.J.; Burstein, S.; Chang, W.H.; Wortham, K.; Sedor, C.; Hunter, S.A. 1982: Prostacyclin production by vein grafts in the arterial circulation: a study in rats. Prostaglandins Leukotrienes and Medicine 9(5): 511-516

Ingerman-Wojenski, C.; Silver, M.J.; Smith, J.B.; Nissenbaum, M.; Sedar, A.W. 1981: Prostacyclin production in rabbit arteries in situ: inhibition by arachidonic acid-induced endothelial cell damage or by low-dose aspirin. Prostaglandins 21(4): 655-666

Spitz, B.; Deckmyn, H.; Van Assche, F.A.; Vermylen, J. 1983: Prostacyclin production in whole blood throughout normal pregnancy. Clinical and Experimental Hypertension. Part B Hypertension in Pregnancy 2(2): 191-202

Quadt, J.F.; Voss, R.; ten Hoor, F. 1982: Prostacyclin production of the isolated pulsatingly perfused rat aorta. Journal of Pharmacological Methods 7(4): 263-270

Matsumura, K.; Watanabe, Y.; Onoe, H.; Watanabe, Y. 1995: Prostacyclin receptor in the brain and central terminals of the primary sensory neurons: an autoradiographic study using a stable prostacyclin analogue [3H]iloprost. Neuroscience 65(2): 493-503

MacDermot, J.; Blair, I.A.; Cresp, T.M. 1981: Prostacyclin receptors of a neuronal hybrid cell line. Divalent citations and ligand-receptor coupling. Biochemical Pharmacology 30(15): 2041-2044

Belch, J.J.; Lowe, D.G.; Drummond, M.M.; Forbes, C.D.; Prentice, C.R. 1981: Prostacyclin reduces red cell deformability. Thrombosis and Haemostasis 45(2): 189

Bennett, A.; Sanger, G.J. 1980: Prostacyclin relaxes the longitudinal muscle of human isolated stomach and antagonizes contractions to some prostanoids. Journal of Physiology 298: 45P-46P

Goldsmith, J.C.; Jafvert, C.T.; Lollar, P.; Owen, W.G.; Hoak, J.C. 1981: Prostacyclin release from cultured and ex vivo bovine vascular endothelium. Studies with thrombin, arachidonic acid, and ionophore A23187. Laboratory Investigation; a Journal of Technical Methods and Pathology 45(2): 191-197

Dandona, P.; Mikhailidis, D.P.; Jeremy, J.Y. 1983: Prostacyclin release in vivo. Lancet 1(8328): 823-824

Mullane, K.M.; Moncada, S.; Vane, J.R. 1980: Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors. Advances in Prostaglandin and Thromboxane Research 7: 1159-1161

Pearson, J.D.; Carleton, J.S.; Hutchings, A. 1983: Prostacyclin release stimulated by thrombin or bradykinin in porcine endothelial cells cultured from aorta and umbilical vein. Thrombosis Research 29(2): 115-124

Krausz, M.M.; Utsunomiya, T.; Feuerstein, G.; Wolfe, J.H.; Shepro, D.; Hechtman, H.B. 1981: Prostacyclin reversal of lethal endotoxemia in dogs. Journal of Clinical Investigation 67(4): 1118-1125

Arze, R.S.; Ward, M.K. 1981: Prostacyclin safer than heparin in haemodialysis. Lancet 2(8236): 50

Gaskill, H.V.; Sirinek, K.R.; Levine, B.A. 1984: Prostacyclin selectively enhances blood flow in areas of the Gi tract prone to stress ulceration. Journal of Trauma 24(5): 397-402

Briel, R.C.; Joos, I.; Brodmann, C. 1984: Prostacyclin sensitivity of thrombocytes and prostacyclin-like activity in the umbilical cord. Zeitschrift für Geburtshilfe und Perinatologie 188(6): 275-278

Larrue, J.; Daret, D.; Demond-Henri, J.; Allières, C.; Bricaud, H. 1984: Prostacyclin synthesis by proliferative aortic smooth muscle cells. a kinetic in vivo and in vitro study. Atherosclerosis 50(1): 63-72

Güllner, H.G. 1983: Prostacyclin synthesis in Bartter's syndrome. Lancet 2(8355): 908

Dadak, C.; Hoche, C.; Ulrich, W.; Sinzinger, H. 1982: Prostacyclin synthesis in human umbilical vessels. Wiener Klinische Wochenschrift 94(20): 550-553

Leithner, C.; Kefalides, A.; Hoche, C.; Sinzinger, H. 1982: Prostacyclin synthesis-stimulating plasma factor in different age groups. Aktuelle Gerontologie 12(6): 217-219

Dadak, C.; Sinzinger, H.; Riss, P.; Ulrich, W.; Leithner, C.; Janisch, H. 1983: Prostacyclin therapy in EPH gestosis (preliminary report). Wiener Klinische Wochenschrift 95(11): 374-377

Yui, Y.; Nakajima, H.; Kawai, C.; Murakami, T. 1982: Prostacyclin therapy in patients with congestive heart failure. American Journal of Cardiology 50(2): 320-324

Budd, G.T.; Bukowski, R.M.; Lucas, F.V.; Cato, A.E.; Cocchetto, D.M. 1980: Prostacyclin therapy of thrombotic thrombocytopenic purpura. Lancet 2(8200): 915

Gimson, A.E.; Langley, P.G.; Hughes, R.D.; Canalese, J.; Mellon, P.J.; Williams, R.; Woods, H.F.; Weston, M.J. 1980: Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet 1(8161): 173-175

Hory, B.; Saunier, F.; Roy, C.; Renevier, A.; Kieffer, Y.; Saint-Hillier, Y.; Perol, C. 1982: Prostacyclin versus regional heparinisation during haemodialysis. La Nouvelle Presse Medicale 11(32): 2393-2397

Szczeklik, A.; Szczeklik, J.; Nizankowski, R. 1981: Prostacyclin, nitroglycerin, and effort angina. Lancet 1(8227): 1006

Milvae, R.A.; Hansel, W. 1983: Prostacyclin, prostaglandin F2 alpha and progesterone production by bovine luteal cells during the estrous cycle. Biology of Reproduction 29(5): 1063-1068

Oikarinen, A.; Viinikka, L.; Rytsälä, H.; Kiistala, U.; Ylikorkala, O. 1981: Prostacyclin, thromboxane and prostaglandin F2 alpha in suction blister fluid of human skin: effect of systemic aspirin and local glucocorticosteroid treatment. Life Sciences 29(4): 391-396

Ylikorkala, O.; Viinikka, L. 1981: Prostacyclin, thromboxane, and prostaglandin F2 alpha in maternal plasma during breast-feeding. American Journal of Obstetrics and Gynecology 139(6): 690-692

Vapaatalo, H. 1980: Prostacyclin--a new biologically active agent. Duodecim; Laaketieteellinen Aikakauskirja 96(3): 175-180

Coker, S.J.; Parratt, J.R. 1983: Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds. Journal of Cardiovascular Pharmacology 5(4): 557-567

Gryglewski, R. 1983: Prostacyclin--experimental and clinical approach. Advances in Prostaglandin Thromboxane and Leukotriene Research 11: 457-461

Higgs, E.A.; Moncada, S. 1983: Prostacyclin--physiology and clinical uses. General Pharmacology 14(1): 7-11

Mitchell, J.R. 1983: Prostacyclin--powerful, yes: but is it useful?. British Medical Journal 287(6408): 1824-1826

Blair, I.A.; Hensby, C.N.; MacDermot, J. 1980: Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: prostanoid structure-activity relationships. British Journal of Pharmacology 69(3): 519-525

Voss, R.; Don, J.A.; ten Hoor, F. 1983: Prostacyclin-formation by the rabbit aorta: relation to atherosclerosis. Prostaglandins Leukotrienes and Medicine 11(4): 451-456

Rubin, L.J.; Groves, B.M.; Reeves, J.T.; Frosolono, M.; Handel, F.; Cato, A.E. 1982: Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 66(2): 334-338

Coker, S.J.; Parratt, J.R. 1981: Prostacyclin-induced changes in coronary blood flow and oxygen handling in the normal and acutely ischaemic canine myocardium. Basic Research in Cardiology 76(4): 457-462

Gaion, R.M.; Trento, M. 1984: Prostacyclin-induced contraction of guinea-pig ileum: influence of drugs affecting calcium flux in the smooth muscle. European Journal of Pharmacology 102(3-4): 529-533

Schrör, K.; Link, H.B.; Rösen, R.; Klaus, W.; Rösen, P. 1980: Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro. European Journal of Pharmacology 64(4): 341-348

Kandasamy, S.B.; Williams, B.A. 1982: Prostacyclin-induced hyperthermia: implication of a protein mediator. Neuropharmacology 21(10): 1065-1072

Kandasamy, S.B.; Kirlin, W.G.; Kaul, P.N. 1981: Prostacyclin-induced hypothermia: involvement of central histamine H2-receptors. Life Sciences 28(22): 2553-2560

Karpati, L.; Chow, F.P.; Woollard, M.L.; Hutton, R.A.; Dandona, P. 1980: Prostacyclin-like activity in the female rat thoracic aorta and the inferior vena cava after ethinyloestradiol and norethisterone. Clinical Science 59(5): 369-372

Bodzenta, A.; Thomson, J.M.; Poller, L.; Burslem, R.W.; Wilcox, F.L. 1981: Prostacyclin-like, and kallikrein activity of amniotic fluid in pre-eclampsia. British Journal of Obstetrics and Gynaecology 88(12): 1217-1222

Gaskill, H.V.; Sirinek, K.R.; Levine, B.A. 1982: Prostacyclin-mediated gastric cytoprotection is dependent on mucosal blood flow. Surgery 92(2): 220-225

Nicosia, S.; Oliva, D.; Bernini, F.; Fumagalli, R. 1984: Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells. Advances in Cyclic Nucleotide and Protein Phosphorylation Research 17: 593-599

Oliva, D.; Noè, A.; Nicosia, S.; Bernini, F.; Fumagalli, R.; Whittle, B.J.; Moncada, S.; Vane, J.R. 1984: Prostacyclin-sensitive adenylate cyclase in cultured myocytes: differences between rabbit aorta and mesenteric artery. European Journal of Pharmacology 105(3-4): 207-213

Mikhailidis, D.P.; Dandona, P. 1982: Prostacyclin-stabilising-factor deficiency in thrombotic thrombocytopenic purpura. Lancet 1(8273): 678-679

Polterauer, P.; Sinzinger, H.; Peskar, B.A. 1984: Prostacyclin-synthesis-stimulating plasma factor in patients with different stages of hepatic coma. Prostaglandins Leukotrienes and Medicine 13(3): 315-321

Schrör, K.; Köhler, P.; Müller, M.; Peskar, B.A.; Rösen, P. 1981: Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart. American Journal of Physiology 241(1): H18-H25

Honn, K.V.; Cicone, B.; Skoff, A. 1981: Prostacyclin: a potent antimetastatic agent. Science 212(4500): 1270-1272

Vane, J.R. 1982: Prostacyclin: a prostaglandin with therapeutic potential. Archivos de Farmacologia y Toxicologia 8(2): 51-76

Linet, O.I. 1982: Prostacyclin: a review of current clinical experience. Postgraduate Medicine 72(6): 105-7 110-20

Gabryelewicz, A.; Długosz, J.; Brzozowski, J.; Musiatowicz, B.; Sidun-Kuryłowicz, Z.; Wereszczyńska, U.; Triebling, A. 1983: Prostacyclin: effect on pancreatic lysosomes in acute experimental pancreatitis in dogs. Mount Sinai Journal of Medicine new York 50(3): 218-224

Sitsen, J.M.; Nijkamp, F.P. 1983: Prostacyclin; clinical aspects. Nederlands Tijdschrift Voor Geneeskunde 127(5): 199-206

Szczeklik, A. 1983: Prostacyclins and myocardial infarct. Polski Tygodnik Lekarski 38(15): 449-451

Szczeklik, A. 1980: Prostacyclins and the development and treatment of arteriosclerosis. Kardiologia Polska 23(7): 537-546

Masek, K.; Kadlec, O. 1980: Prostacyclins and thromboxanes, new substances from the prostanoid group. Casopis Lekaru Ceskych 119(29-30): 785-787

Brus, R. 1983: Prostacyclins, their synthetic analogs and the factors affecting their biosynthesis and release. Polski Tygodnik Lekarski 38(35): 1087-1090

Amy, J.J.; Jackson, D.M.; Ganesan, P.A.; Karim, S.M. 1973: Prostaglandin 15 (R) 15-methyl-E2 methyl ester for suppression of gastric acidity in gravida at term. British Medical Journal 4(5886): 208-211

Chang, D.G.; Sun, M.; Tai, H.H. 1981: Prostaglandin 9-ketoreductase and type Ii 15-hydroxyprostaglandin dehydrogenase from swine kidney are alternate activities of a single enzyme protein. Biochemical and Biophysical Research Communications 99(2): 745-751

Chang, D.G.; Tai, H.H. 1981: Prostaglandin 9-ketoreductase/type Ii 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme. Biochemical and Biophysical Research Communications 101(3): 898-904

Santoro, M.G.; Benedetto, A.; Carruba, G.; Garaci, E.; Jaffe, B.M. 1980: Prostaglandin a compounds as antiviral agents. Science 209(4460): 1032-1034

Santoro, M.G.; Jaffe, B.M.; Esteban, M. 1983: Prostaglandin a inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. Journal of General Virology 64: 2797-2801

Bregman, M.D.; Sander, D.; Meyskens, F.L. 1982: Prostaglandin A1 and E1 inhibit the plating efficiency and proliferation of murine melanoma cells (Cloudman S-91) in soft agar. Biochemical and Biophysical Research Communications 104(3): 1080-1086

Slotkoff, L.M. 1974: Prostaglandin A1 in hypertensive crisis. Annals of Internal Medicine 81(3): 345-347

Santoro, M.G.; Jaffe, B.M.; Elia, G.; Benedetto, A. 1982: Prostaglandin A1 induces the synthesis of a new protein in cultured AGMK cells. Biochemical and Biophysical Research Communications 107(4): 1179-1184

Eisenbarth, G.S.; Wellman, D.K.; Lebovitz, H.E. 1974: Prostaglandin A1 inhibition of chondrosarcoma growth. Biochemical and Biophysical Research Communications 60(4): 1302-1308

Lee, J.B.; McGiff, J.C.; Kannegiesser, H.; Aykent, Y.Y.; Mudd, J.G.; Frawley, T.F. 1971: Prostaglandin A1: antihypertensive and renal effects. Studies in patients with essential hypertension. Annals of Internal Medicine 74(5): 703-710

Himori, N.; Burkman, A.M. 1983: Prostaglandin B1 can modify the pressor responses to sympathetic nerve stimulation. Research Communications in Chemical Pathology and Pharmacology 41(3): 397-405

Greenberg, S.; Engelbrecht, J.A.; Wilson, W.R. 1974: Prostaglandin B2-induced cutaneous vasoconstriction of the canine hind paw. Circulation Research 34(4): 491-497

Spatz, M.; Stanimirovic, D.; Uematsu, S.; Roberts, L.J.; Bembry, J.; McCarron, R.M. 1993: Prostaglandin D2 and endothelin-1 induce the production of prostaglandin F2 alpha, 9 alpha, 11 beta-prostaglandin F2, prostaglandin E2, and thromboxane in capillary endothelium of human brain. Prostaglandins Leukotrienes and Essential Fatty Acids 49(4): 789-793

Lewis, R.A.; Soter, N.A.; Diamond, P.T.; Austen, K.F.; Oates, J.A.; Roberts, L.J. 1982: Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Journal of Immunology 129(4): 1627-1631

Rao, P.S.; Cavanagh, D.; Marsden, K.A.; Knuppel, R.A.; Spaziani, E. 1984: Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. American Journal of Obstetrics and Gynecology 148(7): 964-972

Narumiya, S.; Ogorochi, T.; Nakao, K.; Hayaishi, O. 1982: Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sciences 31(19): 2093-2103

Gaetani, P.; Rodriguez y Baena, R.; Vigano, T.; Crivellari, M.T. 1983: Prostaglandin D2 in subarachnoid hemorrhage. Biological and diagnostic implications. Rivista di Patologia Nervosa E Mentale 104(4): 171-177

Ueno, R.; Ishikawa, Y.; Nakayama, T.; Hayaishi, O. 1982: Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochemical and Biophysical Research Communications 109(2): 576-582

Philips, J.B.; Lyrene, R.K.; McDevitt, M.; Perlis, W.; Satterwhite, C.; Cassady, G. 1983: Prostaglandin D2 inhibits hypoxic pulmonary vasoconstriction in neonatal lambs. Journal of Applied Physiology: Respiratory Environmental and Exercise Physiology 54(6): 1585-1589

Smith, J.B.; Silver, M.J.; Ingerman, C.M.; Kocsis, J.J. 1974: Prostaglandin D2 inhibits the aggregation of human platelets. Thrombosis Research 5(3): 291-299

Sakai, T.; Yamaguchi, N.; Kawai, K.; Nishino, H.; Iwashima, A. 1983: Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells. Cancer Letters 17(3): 289-294

Soifer, S.J.; Morin, F.C.; Heymann, M.A. 1982: Prostaglandin D2 reverses induced pulmonary hypertension in the newborn lamb. Journal of Pediatrics 100(3): 458-463

Miyake, A.; Tasaka, K.; Mori, S.; Saito, Y.; Aono, T. 1983: Prostaglandin D2 stimulates secretion of luteinizing hormone from pituitary gland in vitro. Acta Endocrinologica 104(2): 164-166

Shimatsu, A.; Kato, Y.; Matsushita, N.; Ohta, H.; Kabayama, Y.; Yanaihara, N.; Imura, H. 1984: Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood. Peptides 5(2): 395-398

Kawamura, M.; Koshihara, Y. 1983: Prostaglandin D2 strongly inhibits growth of murine mastocytoma cells. Prostaglandins Leukotrienes and Medicine 12(1): 85-93

Closa, D.; Roselló-Catafau, J.; Fernández-Cruz, L.; Gelpí, E. 1994: Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats. Pancreas 9(1): 73-77

Fukushima, M.; Kato, T.; Ueda, R.; Ota, K.; Narumiya, S.; Hayaishi, O. 1982: Prostaglandin D2, a potential antineoplastic agent. Biochemical and Biophysical Research Communications 105(3): 956-964

Hayaishi, O. 1983: Prostaglandin D2: a neuromodulator. Advances in Prostaglandin Thromboxane and Leukotriene Research 12: 333-337

Thomas, D.R.; Philpott, G.W.; Jaffe, B.M. 1974: Prostaglandin e (PGE) control of cell proliferation in vitro: characteristics of HT-29. Journal of Surgical Research 16(5): 463-465

Zurier, R.B.; Ballas, M. 1973: Prostaglandin E 1 (PGE 1 ) suppression of adjuvant arthritis. Histopathology. Arthritis and Rheumatism 16(2): 251-257

Arienti, S.; Piccinini, F.; Pomarelli, P. 1967: Prostaglandin e 1 (PGE 1) and calcium metabolism at the level of the myocardial cell. Bollettino della Societa Italiana di Biologia Sperimentale 43(10): 521-524

Labhsetwar, A.P. 1973: Prostaglandin e 1 : studies on antifertility and luteolytic effects in hamsters and rats. Biology of Reproduction 8(1): 103-111

Elkeles, R.S.; Hampton, J.R.; Harrison, M.J.; Mitchell, J.R. 1969: Prostaglandin e 1 and human platelets. Lancet 2(7611): 111

Fantin, G.P.; Aragno, R. 1974: Prostaglandin e 1 and neuromuscular transmission in the frog. Bollettino della Societa Italiana di Biologia Sperimentale 50(16-2): 1265-1268

Maganiello, V.; Vaughan, M. 1972: Prostaglandin e 1 effects on adenosine 3':5'-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts (mouse L cells-tissue culture-enzyme kinetics-prostaglandin homologues). Proceedings of the National Academy of Sciences of the United States of America 69(1): 269-273

Kirtland, S.J.; Baum, H. 1972: Prostaglandin E 1 may act as a "calcium ionophore". Nature: New Biology 236(63): 47-49

Srivastava, K.C.; Bansal, R.K.; Tiwari, K.P. 1981: Prostaglandin e and 19-hydroxy prostaglandin e content in the semen of men with normal sperm characteristics, men with abnormal sperm characteristics, vasectomised men and polyzoospermic men. Danish Medical Bulletin 28(5): 201-203

Hillier, K.; Smith, M.D. 1981: Prostaglandin e and F concentrations in placentae of normal, hypertensive and pre-eclamptic patients. British Journal of Obstetrics and Gynaecology 88(3): 274-277

Hofmann, G.E.; Rao, C.V.; Barrows, G.H.; Rossano, L.T.; Sanfilippo, J.S. 1984: Prostaglandin e and F2 alpha receptors in human uterine leiomyomas. Journal of Clinical Endocrinology and Metabolism 58(3): 454-457

Horton, E.W. 1980: Prostaglandin e and schizophrenia. Lancet 1(8163): 313

Löning, T.; Albers, H.K.; Lisboa, B.P.; Burkhardt, A.; Caselitz, J. 1980: Prostaglandin e and the local immune response in chronic periodontal disease. Immunohistochemical and radioimmunological observations. Journal of Periodontal Research 15(5): 525-535

Hofer, D.; Dubitsky, A.; Marti, J.; Santoro, M.G.; Reilly, P.; Jaffe, B.M. 1982: Prostaglandin e augments the effect of chemotherapy on B-16 melanoma in vivo. Journal of Surgical Research 32(6): 555-562

Hedqvist, P. 1971: Prostaglandin e compounds and sympathetic neuromuscular transmission. Annals of the new York Academy of Sciences 180: 410-415

Rappaport, R.S.; Dodge, G.R. 1982: Prostaglandin e inhibits the production of human interleukin 2. Journal of Experimental Medicine 155(3): 943-948

Sitrin, R.G.; Kaltreider, H.B.; Goldyne, M.E. 1984: Prostaglandin e is required for the augmentation of procoagulant activity of LPS-stimulated rabbit alveolar macrophages. Journal of Immunology 132(2): 867-871

Moore, T.C.; Jaffe, B.M. 1974: Prostaglandin e levels of heterotopic rat heart allografts and host lymphoid tissues at intervals postgrafting. Transplantation 18(4): 383-385

Cardinali, D.P.; Ritta, M.N.; Fuentes, A.M.; Gimeno, M.F.; Gimeno, A.L. 1980: Prostaglandin e release by rat medial basal hypothalamus in vitro. Inhibition by melatonin at submicromolar concentrations. European Journal of Pharmacology 67(1): 151-153

Stjärne, L. 1972: Prostaglandin e restricting noradrenaline secretion--neural in origin?. Acta Physiologica Scandinavica 86(4): 574-576

Sato, K.; Abe, K.; Sato, M.; Haruyama, T.; Yasujima, M.; Hiwatari, M.; Tajima, J.; Kasai, Y.; Chiba, S.; Seino, M.; Yoshinaga, K. 1982: Prostaglandin e synthesis in the kidney in renin subgroups of essential hypertension. Prostaglandins Leukotrienes and Medicine 9(5): 577-585

Olariu-Ungureanu, A.; Socaciu, A.; Săvulescu, M.; Stoica, E.; Atanasiu, M.; Velciu, V. 1980: Prostaglandin E, metabolic ligand with clinical and therapeutic implications in some congenital heart diseases and pulmonary diseases in infants. Revista de Pediatrie Obstetrica Si Ginecologie. Pediatria 29(1): 23-32

Hsieh, B.S. 1983: Prostaglandin E--vasopressin interrelation in the syndrome of inappropriate secretion of antidiuretic hormone. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 82(4): 481-489

Kyle, V.; Hazleman, B. 1983: Prostaglandin E-1 and peripheral vascular disease. Lancet 2(8344): 282

Kaley, G.; Weiner, R. 1971: Prostaglandin E-1: a potential mediator of the inflammatory response. Annals of the new York Academy of Sciences 180: 338-350

Karaplis, A.C.; Powell, W.S. 1981: Prostaglandin E-binding sites in the fetal adrenal. Endocrinology 109(6): 2124-2128

Garrity, M.J.; Andreasen, T.J.; Storm, D.R.; Robertson, R.P. 1983: Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. Consequences on the guanyl nucleotide regulatory complex. Journal of Biological Chemistry 258(14): 8692-8697

Marks, F.; Fürstenberger, G.; Kownatzki, E. 1981: Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore a 23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Research 41(2): 696-702

Piccinini, F.; Pomarelli, P. 1967: Prostaglandin E1 (PGE1) and calcium transport. (Experiments according to a specially simple pattern). Bollettino della Societa Italiana di Biologia Sperimentale 43(21): 1412-1414

Meriggi, F.; Mellerio, G.; Samanni, G.; Wagner, V.; Scotti-Foglieni, C. 1984: Prostaglandin E1 (PGE1) gastric tissue levels in the rat after truncal vagotomy and/or pre-hepatic portal hypertension. Italian Journal of Surgical Sciences 14(1): 37-42

Carlson, L.A.; Ericsson, M.; Erikson, U. 1973: Prostaglandin E1 (PGE1) in peripheral arteriographies. Acta Radiologica: Diagnosis 14(5): 583-587

Laudanno, O.M.; Finkelstein, D.; Capdepon, E. 1984: Prostaglandin E1 (misoprostol) and S-adenosylmethionine in the prevention of hemorrhagic gastritis induced by aspirin in the human. Endoscopic, histologic and histochemical study. Acta Gastroenterologica Latinoamericana 14(4): 289-293

Williams, G.; Pickup, J.C.; Collins, A.C.; Keen, H. 1984: Prostaglandin E1 accelerates subcutaneous insulin absorption in insulin-dependent diabetic patients. Diabetic Medicine: a Journal of the British Diabetic Association 1(2): 109-113

Mruk, J.; Bakardjiev, A.; Burgermeister, W. 1982: Prostaglandin E1 action on adenylate cyclase activity and membrane lipids in platelets. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 363(7): 745-756

Laburn, H.P. 1974: Prostaglandin E1 and fever. South African Medical Journal 1974(0 Suppl): 40-41

Hall, W.J.; Martin, J.D. 1973: Prostaglandin E1 and net water flow across isolated frog skin. Journal of Physiology 232(2): 85P-86P

Ginsborg, B.L.; Hirst, G.D. 1971: Prostaglandin E1 and noradrenaline at the neuromuscular junction. British Journal of Pharmacology 42(1): 153-154

Bousser, M.G. 1973: Prostaglandin E1 and platelets. Biomedicine / 18(2): 95-102

Smith, M.E.; Holcroft, J.W.; Demling, R.H. 1982: Prostaglandin E1 and prostacyclin infusion decrease thromboxane production in endotoxin-induced lung injury. Journal of Surgical Research 32(3): 283-288

Fantone, J.C.; Kinnes, D.A. 1983: Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochemical and Biophysical Research Communications 113(2): 506-512

Goto, F.; Otani, E.; Kato, S.; Fujita, T. 1982: Prostaglandin E1 as a hypotensive drug during general anaesthesia. Anaesthesia 37(5): 530-535

Jackson, R.T. 1970: Prostaglandin E1 as a nasal constrictor in normal human volunteers. Current Therapeutic Research 12(11): 711-717

Machiedo, G.W.; Brown, C.S.; Lavigne, J.E.; Rush, B.F. 1973: Prostaglandin E1 as a therapeutic agent in hemorrhagic shock. Surgical Forum 24: 12-14

Donahoo, J.S.; Roland, J.M.; Kan, J.; Gardner, T.J.; Kidd, B.S. 1981: Prostaglandin E1 as an adjunct to emergency cardiac operation in neonates. Journal of Thoracic and Cardiovascular Surgery 81(2): 227-231

Wennmalm, A.; Hedqvist, P. 1970: Prostaglandin E1 as inhibitor of the sympathetic neuroffector system in the rabbit heart. Life Sciences.(Part 1): Physiology and Pharmacology 9(16): 931-937

Vargas, A.V.; Krishnamurthi, V.; Masih, R.; Robinson, A.V.; Schulak, J.A. 1995: Prostaglandin E1 attenuation of ischemic renal reperfusion injury in the rat. Journal of the American College of Surgeons 180(6): 713-717

Davies, P.J.; Chabay, R.; Zech, L.; Berman, M.; Pastan, I. 1980: Prostaglandin E1 binding and adenylate cyclase activation in normal and transformed fibroblasts. Biochimica et Biophysica Acta 629(2): 282-291

Nakaseko, C.; Oh, H.; Sato, H.; Cho, R.; Ishii, A.; Ikegami, T.; Kogure, K.; Fukazawa, M.; Yokota, A.; Kawano, E. 1995: Prostaglandin E1 bladder instillations for late-onset hemorrhagic cystitis following allogeneic bone marrow transplantation. Japanese Journal of Clinical Hematology 36(8): 728-734

Haubrich, D.R.; Perez-Cruet, J.; Reid, W.D. 1973: Prostaglandin E1 causes sedation and increases 5-hydroxytryptamine turnover in rat brain. British Journal of Pharmacology 48(1): 80-87

Povzhitkov, M.; Haendchen, R.V.; Meerbaum, S.; Fishbein, M.C.; Shell, W.; Corday, E. 1984: Prostaglandin E1 coronary venous retroperfusion in acute myocardial ischemia: effects on regional left ventricular function and infarct size. Journal of the American College of Cardiology 3(4): 939-947

Gustafson, T.; Hedner, P.; Ingemansson, S. 1982: Prostaglandin E1 effect on human splanchnic circulation at different dose levels. Investigative Radiology 17(3): 249-253

Bem, J.L.; Greaves, M.W. 1974: Prostaglandin E1 effects on epidermal cell growth "in vitro". Archiv für Dermatologische Forschung 251(1): 35-41

Levy, J.M.; Ibrahim, F.; Nykamp, P.W.; Weiland, D.E. 1984: Prostaglandin E1 for alleviating symptoms of ergot intoxication: a case report. Cardiovascular and Interventional Radiology 7(1): 28-30

Sasso, S.C. 1983: Prostaglandin E1 for infants with congenital heart disease. Mcn. American Journal of Maternal Child Nursing 8(1): 29

Francesconi, R.; Mager, M. 1981: Prostaglandin E1 hyperthermia: effects on ability to work in the heat. Journal of Applied Physiology: Respiratory Environmental and Exercise Physiology 51(1): 62-67

Lieb, J. 1980: Prostaglandin E1 in affective disorders and alcoholism. British Medical Journal 281(6237): 453

Levy, J.M.; Joseph, R.B.; Bodell, L.S.; Nykamp, P.W.; Hessel, S.J. 1983: Prostaglandin E1 in hand angiography. Ajr. American Journal of Roentgenology 141(5): 1043-1046

Dungan, W.T.; Norton, J.B.; Readinger, R.I.; Sotomora, R.F. 1982: Prostaglandin E1 in neonates with critical congenital heart disease. Journal of the Arkansas Medical Society 79(5): 167-170

Kassis, V.; Søndergaard, J. 1983: Prostaglandin E1 in normal human skin: methodological evaluation, topographical distribution and data related to sex and age. Archives of Dermatological Research 275(1): 9-13

Fernandez, N.A.; Rosenberg, V.; Lee, M.; Singer, A. 1983: Prostaglandin E1 in obstructive peripheral vascular disease. Mount Sinai Journal of Medicine new York 50(3): 213-217

Pardy, B.J.; Hoare, M.C.; Eastcott, H.H.; Miles, C.C.; Needham, T.N.; Harbourne, T.; Ellis, B.W. 1982: Prostaglandin E1 in severe Raynaud's phenomenon. Surgery 92(6): 953-965

Telles, G.S.; Campbell, W.B.; Wood, R.F.; Collin, J.; Baird, R.N.; Morris, P.J. 1984: Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial. British Journal of Surgery 71(7): 506-508

Kassis, V.; Mortensen, T.; Søndergaard, J. 1981: Prostaglandin E1 in suction-separated human epidermal tissue in primary irritant dermatitis. Acta Dermato-Venereologica 61(5): 429-431

Hallidie-Smith, K.A. 1984: Prostaglandin E1 in suspected ductus dependent cardiac malformation. Archives of Disease in Childhood 59(11): 1020-1026

Loran, O.B.; Segal, A.S.; Shcheplev, P.A. 1995: Prostaglandin E1 in the diagnosis and therapy of erectile disorders. Urologiia i Nefrologiia 4: 35-38

Schleman, M.M.; Casta, A.; Mongkolsmai, C.; Black, I.F. 1980: Prostaglandin E1 in the neonate with heart disease. Advances in Prostaglandin and Thromboxane Research 7: 879-881

Leffler, C.W.; Amberson, J.I. 1982: Prostaglandin E1 increases blood flow to the cervix uteri. Prostaglandins Leukotrienes and Medicine 8(1): 27-30

Roux, S.; Latour, J.G.; Théroux, P.; Clozel, J.P.; Bourassa, M.G. 1984: Prostaglandin E1 increases myocardial contractility in the conscious dog. Canadian Journal of Physiology and Pharmacology 62(12): 1505-1510

Hargrove, J.L.; Johnson, J.M.; Ellis, L.C. 1971: Prostaglandin E1 induced inhibition of rabbit testicular contractions in vitro. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 136(3): 958-961

Yu, J.H.; Burns, S.; Schneyer, C.A. 1982: Prostaglandin E1 induced salivary secretion. Experientia 38(9): 1077-1078

Nassar, C.F.; Nakhkhul, N.L. 1981: Prostaglandin E1 influx across mucosal membrane of mammalian intestine. Digestion 22(5): 276-280

Hastreiter, A.R.; van der Horst, R.L.; Sepehri, B.; DuBrow, I.W.; Fisher, E.A.; Levitsky, S. 1982: Prostaglandin E1 infusion in newborns with hypoplastic left ventricle and aortic atresia. Pediatric Cardiology 2(2): 95-98

Linday, L.; Levin, A.R.; Reitman, M.; Engle, M.A. 1981: Prostaglandin E1 infusion: successful initial treatment. New York State Journal of Medicine 81(2): 218-221

Martin, M.F.; Dowd, P.M.; Ring, E.F.; Cooke, E.D.; Dieppe, P.A.; Kirby, J.D. 1981: Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. Annals of the Rheumatic Diseases 40(4): 350-354

Nilsson, J.; Olsson, A.G. 1984: Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis 53(1): 77-82

Kelley, V.E.; Winkelstein, A.; Izui, S.; Dixon, F.J. 1981: Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice. Clinical Immunology and Immunopathology 21(2): 190-203

Mizushima, Y.; Yanagawa, A.; Hoshi, K. 1983: Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man. Journal of Pharmacy and Pharmacology 35(10): 666-667

Hausman, R.E.; Velleman, S.G. 1981: Prostaglandin E1 receptors on chick embryo myoblasts. Biochemical and Biophysical Research Communications 103(1): 213-218

Kashani, I.A.; Schmunk, G.A.; Merritt, T.A.; Swensson, R.E.; Utley, J.R. 1984: Prostaglandin E1 responsive ductus at 11 months of age. Pediatric Cardiology 5(1): 19-21

McCall, E.; Youlten, L.J. 1973: Prostaglandin E1 synthesis by phagocytosing rabbit polymorphonuclear leucocytes: its inhibition by indomethacin and its role in chemotaxis. Journal of Physiology 234(2): 98P

Baron, M.; Skrinskas, G.; Urowitz, M.B.; Madras, P.N. 1982: Prostaglandin E1 therapy for digital ulcers in scleroderma. Canadian Medical Association Journal 126(1): 42-45

Wennmalm, A. 1982: Prostaglandin therapy for peripheral vascular disease - better than placebo?. Clinical Physiology 2(2): 85-87

McLeish, K.R.; Gohara, A.F.; Gunning, W.T.; Senitzer, D. 1980: Prostaglandin E1 therapy of murine chronic serum sickness. Journal of Laboratory and Clinical Medicine 96(3): 470-479

Fleming, W.H.; Sarafian, L.B.; Kobayashi, R.H. 1984: Prostaglandin E1 therapy. Is it associated with a higher incidence of wound infection in the cyanotic neonate?. Chest 85(2): 241-243

Carey, B.E. 1982: Prostaglandin E1 treatment for neonatal heart defects. Dimensions of Critical Care Nursing: Dccn 1(5): 275-283

Crocket, K.V.; Brackett, K.; Crocket, A.; Jacobson, E.D.; Rao, S.S.; Joffe, S.N. 1984: Prostaglandin E1 treatment in experimental acute pancreatitis in the rat. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 16(5): 265-273

Beitner, H.; Hammar, H.; Olsson, A.G.; Thyresson, N. 1980: Prostaglandin E1 treatment of leg ulcers caused by venous or arterial incompetence. Acta Dermato-Venereologica 60(5): 425-430

Linehan, J.H.; Dawson, C.A.; Wagner-Weber, V.M. 1981: Prostaglandin E1 uptake by isolated cat lungs perfused with physiological salt solution. Journal of Applied Physiology: Respiratory Environmental and Exercise Physiology 50(2): 428-434

Merriman, C.R.; Upchurch, H.F.; Kampschmidt, R.F. 1974: Prostaglandin E1, aspirin and the action of leukocytic endogenous mediator. Journal of Pharmacology and Experimental Therapeutics 188(3): 516-519

Shimoyama, R.; Hirayama, A.; Moriya, H. 1982: Prostaglandin E1-induced glucagon secretion under propranolol treatment in a case of idiopathic hyperglucagonemia. Hokkaido Journal of Medical Science 57(6): 722-726

Pateromichelakis, S.; Rood, J.P. 1982: Prostaglandin E1-induced sensitization of A delta moderate pressure mechanoreceptors. Brain Research 232(1): 89-96

Verma, D.S.; Spitzer, G.; Zander, A.R.; McCredie, K.B.; Dicke, K.A. 1981: Prostaglandin E1-mediated augmentation of human granulocyte-macrophage progenitor cell growth in vitro. Leukemia Research 5(1): 65-71

Lamprecht, S.A.; Krawiec, J.; Schwartz, B.; Krugliak, P.; Goldstein, J.; Odes, H.S. 1982: Prostaglandin E1-stimulable cyclic AMP formation from rat gastric antral organ culture: lack of effect on gastrin secretion. Biochemical and Biophysical Research Communications 108(1): 186-192

Chirkov, Y.Y.; Sobolev, A.S. 1984: Prostaglandin E1: cAMP level and radiosensitivity of cultured B-82 cells. Strahlentherapie 160(8): 521-522

Sondergaard, J.; Greaves, M.W. 1971: Prostaglandin E1: effect on human cutaneous vasculature and skin histamine. British Journal of Dermatology 84(5): 424-428

Geumei, A.; Bashour, F.A.; Swamy, B.V.; Nafrawi, A.G. 1973: Prostaglandin E1: its effects on hepatic circulation in dogs. Pharmacology 9(6): 336-347

Nishi, S.; Seino, Y.; Seino, S.; Tsuda, K.; Takemura, J.; Ishida, H.; Imura, H. 1982: Prostaglandin E1: stimulation of somatostatin and insulin responses to glucose from the isolated perfused rat pancreas. Prostaglandins Leukotrienes and Medicine 8(6): 593-597

Tobian, L.; Johnson, M.A.; Ganguli, M.; Goto, A.; Iwai, J. 1981: Prostaglandin E2 (PGE2) in renal papilla in NaCl hypertension. Progress in Lipid Research 20: 501-503

Atik, O.S.; Surat, A.; Göğüş, M.T. 1983: Prostaglandin E2 - like activity and senile osteoporosis. Prostaglandins Leukotrienes and Medicine 11(1): 105-107

Kaneti, J.; Thomson, D.M.; Reid, E.C. 1981: Prostaglandin E2 affects the tumor immune response in prostatic carcinoma. Journal of Urology 126(1): 65-70

Roman, R.J.; Lechene, C. 1981: Prostaglandin E2 and F2 alpha reduces urea reabsorption from the rat collecting duct. American Journal of Physiology 241(1): F53-F60

Januszewicz, P.; Wyszyńska, T.; Ignanowska-Switalska, H. 1983: Prostaglandin E2 and F2 excretion in children with glomerulonephritis. Pediatria Polska 58(3): 243-248

Satoh, H.; Satoh, S. 1984: Prostaglandin E2 and I2 production in isolated dog renal arteries in the absence or presence of vascular endothelial cells. Biochemical and Biophysical Research Communications 118(3): 873-876

Szczeklik, A. 1995: Prostaglandin E2 and aspirin-induced asthma. Lancet 345(8956): 1056

Arendorf, T.M. 1981: Prostaglandin E2 and bone and root resorption in hamsters. Journal of the Dental Association of South Africa 36(5): 317-322

Malachi, T.; Chaimoff, C.; Feller, N.; Halbrecht, I. 1981: Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients. Journal of Cancer Research and Clinical Oncology 102(1): 71-79

Okabe, E.; Oyama, M.; Tanaka, T.; Shimura, T.; Ito, H. 1980: Prostaglandin E2 and cyclic nucleotides during anaphylactic shock in rats. Japanese Journal of Pharmacology 30(6): 773-781

Calabrese, J.R.; Gulledge, A.D. 1984: Prostaglandin E2 and depression. Biological Psychiatry 19(8): 1269-1271

Bennett, A.; Stamford, I.F.; Unger, W.G. 1973: Prostaglandin E2 and gastric acid secretion in man. Journal of Physiology 229(2): 349-360

Bonney, R.J.; Burger, S.; Davies, P.; Kuehl, F.A.; Humes, J.L. 1980: Prostaglandin E2 and prostacyclin elevate cyclic AMP levels in elicited populations of mouse peritoneal macrophages. Advances in Prostaglandin and Thromboxane Research 8: 1691-1693

Sterin, A.B.; Linares, J.A.; Goldraij, A.; Gimeno, M.F.; Gimeno, A.L. 1984: Prostaglandin E2 and prostaglandin F2 regulation of triglyceride levels in uterine smooth muscle from restricted-diet estrous and diestrous rats. Prostaglandins Leukotrienes and Medicine 14(3): 391-401

Vikse, A.; Holdaas, H.; Sejersted, O.M.; Eide, I.; Kiil, F. 1983: Prostaglandin E2 and renin release response to dilation of afferent arterioles and during alpha- and beta-adrenergic stimulation. Acta Medica Scandinavica. Supplementum 677: 44-47

Henzl, M.R.; Ortega, E.; Cortés-Gallegos, V.; Tomlinson, R.V.; Segre, E.J. 1973: Prostaglandin E2 and the luteal phase of the menstrual cycle: effects on blood progesterone, estradiol, cortisol, and growth hormone levels. Journal of Clinical Endocrinology and Metabolism 36(4): 784-787

Main, I.H.; Whittle, B.J. 1974: Prostaglandin E2 and the stimulation of rat gastric acid secretion by dibutyryl cyclic 3',5'-AMP. European Journal of Pharmacology 26(2): 204-211

Coceani, F.; Bishai, I.; Dinarello, C.A.; Fitzpatrick, F.A. 1983: Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat. American Journal of Physiology 244(6): R785-R793

Dominguez, J.H.; Puschett, J.B. 1984: Prostaglandin E2 antagonizes the renal effects of parathyroid hormone but not those mediated by a cyclic AMP analog. Mineral and Electrolyte Metabolism 10(4): 267-270

Goldyne, M.E.; Stobo, J.D. 1980: Prostaglandin E2 as a modulator of macrophage-T lymphocyte interactions. Journal of Investigative Dermatology 74(5): 297-300

Broughton Pipkin, F.; Hunter, J.C.; Turner, S.R.; O'Brien, P.M. 1982: Prostaglandin E2 attenuates the pressor response to angiotensin II in pregnant subjects but not in nonpregnant subjects. American Journal of Obstetrics and Gynecology 142(2): 168-176

Dziak, R.M.; Hurd, D.; Miyasaki, K.T.; Brown, M.; Weinfeld, N.; Hausmann, E. 1983: Prostaglandin E2 binding and cyclic AMP production in isolated bone cells. Calcified Tissue International 35(2): 243-249

Deribas, V.I.; Bersimbaev, R.I.; Tairov, M.M. 1984: Prostaglandin E2 binding by gastric mucosa cells in the rat. Arkhiv Anatomii Gistologii i Embriologii 87(9): 62-68

Yun, J.C.; Gill, J.R.; Ho, S.S.; Kelly, G.D.; Keiser, H.R. 1984: Prostaglandin E2 but not F2 alpha restores the natriuretic response to acetylcholine in indomethacin-treated dogs. American Journal of Physiology 247(1 Part 2): F185-F191

Bishai, I.; Coceani, F. 1980: Prostaglandin E2 catabolism in the spinal nerve roots of the cat. Canadian Journal of Physiology and Pharmacology 58(2): 227-229

Craft, I.L.; Cullum, A.R.; May, D.T.; Noble, A.D.; Thomas, D.J. 1971: Prostaglandin E2 compared with oxytocin for the induction of labour. British Medical Journal 3(5769): 276-279

Marino, L.R.; Blumer, J.L.; Halpin, T.C. 1983: Prostaglandin E2 concentration in gastric secretions of critically ill, full-term, and premature infants. Pediatric Research 17(8): 669-671

Herman, J.; Rabson, A.R. 1984: Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes. Clinical and Experimental Immunology 57(2): 380-384

Marshall, P.J.; Dixon, J.F.; Hokin, L.E. 1982: Prostaglandin E2 derived from phosphatidylinositol breakdown in the exocrine pancreas facilitates secretion by an action on the ducts. Journal of Pharmacology and Experimental Therapeutics 221(3): 645-649

Moses, R.A.; Parkison, G.; Snower, D.P. 1981: Prostaglandin E2 effect on the facility of outflow in the rabbit eye. Annals of Ophthalmology 13(6): 721-723

Subbiah, M.T.; Yunker, R.L.; Deitemeyer, D. 1982: Prostaglandin E2 enhances aortic permeability to injected patent blue violet dye and [C14]-cholesterol in the rat: a potential role for PGE2 in atherogenesis. Virchows Archiv. B Cell Pathology Including Molecular Pathology 40(1): 113-115

Sica, D.A.; Midha, M.; Zawada, E.T.; Johnson, M.; Hussey, R.W.; Stacy, W.K. 1984: Prostaglandin E2 excretion in spinal cord injury patients. Journal of the American Paraplegia Society 7(2): 27-30

Lote, C.J.; McVicar, A.J.; Thewles, A. 1983: Prostaglandin E2 excretion, urine flow and papillary osmolality during saline or dextrose infusion in the conscious rat. Journal of Physiology 336: 39-46

Feeney, J.G.; Basu, S.B. 1981: Prostaglandin E2 gel as a routine method of labour induction. Irish Medical Journal 74(3): 93-94

Arakawa, T.; Kobayashi, J.; Nakamura, H.; Chono, S.; Yamada, H. 1981: Prostaglandin E2 improves cimetidine-uneffected intractable gastric ulcers. Nihon Shokakibyo Gakkai Zasshi 78(5): 1121

Aly, A.; Gréen, K.; Johansson, C. 1984: Prostaglandin E2 in basal gastric secretion and during stimulation of muscarinic receptors in man. Measurements with gas chromatography--mass spectrometry. Acta Physiologica Scandinavica 122(4): 583-588

Konturek, S.J.; Radecki, T.; Brzozowski, T.; Piastucki, I.; Dembińska-Kieć, A.; Zmuda, A.; Gryglewski, R. 1981: Prostaglandin E2 in gastric mucosa and its role in the prevention of ulcers induced by acetyl salicylic acid in cats. Digestion 21(4): 205-213

Schlemmer, M.; Khoss, A.; Salzer, H.R.; Wimmer, M. 1982: Prostaglandin E2 in newborns with congenital heart disease. Zeitschrift für Kardiologie 71(7): 452-457

Kremer, M.; Baikoff, G.; Charbonnel, B. 1983: Prostaglandin E2 in side effects of ocular surgery in man: preventive action of indomethacin. Advances in Prostaglandin Thromboxane and Leukotriene Research 12: 121-126

Nakamura, H.; Kobayashi, K.; Arakawa, T.; Hatayama, M.; Kamata, T.; Ono, T. 1981: Prostaglandin E2 in the gastric mucosa (5th report). Effect of carbon tetrachloride--induced liver injury. Nihon Shokakibyo Gakkai Zasshi 78(10): 1915-1919

Arakawa, T.; Nakamura, H.; Chono, S.; Yamada, H.; Kobayashi, K. 1981: Prostaglandin E2 in the gastric mucosa. (3rd report) -Effect of mild acid-. Nihon Shokakibyo Gakkai Zasshi 78(1): 20-23

Arakawa, T.; Nakamura, H.; Kobayashi, K. 1981: Prostaglandin E2 in the rat gastric mucosa (3rd report) --effect of cimetidine. Nihon Shokakibyo Gakkai Zasshi 78(3): 647-652

Arakawa, T.; Nakamura, H.; Chono, S.; Yamada, H.; Kobayashi, K. 1980: Prostaglandin E2 in the rat gastric mucosa (first report). Establishment of assay procedure and effects of nonsteroidal antiinflammatory compounds. Nihon Shokakibyo Gakkai Zasshi 77(7): 1052-1059

Arakawa, T.; Nakamura, H.; Kobayashi, K. 1980: Prostaglandin E2 in the rat gastric mucosa (second report)--effect of water-immersion stress. Nihon Shokakibyo Gakkai Zasshi 77(11): 1711-1716

Ritta, M.N.; Cardinali, D.P. 1981: Prostaglandin E2 increases adenosine 3',5'-monophosphate concentration and binding-site occupancy, and stimulates serotonin-N-acetyltransferase activity in rat pineal glands in vitro. Molecular and Cellular Endocrinology 23(2): 151-159

Pateromichelakis, S.; Rood, J.P. 1981: Prostaglandin E2 increases mechanically evoked potentials in the peripheral nerve. Experientia 37(3): 282-284

Takigawa, M.; Takashiba, S.; Takahashi, K.; Arai, H.; Kurihara, H.; Murayama, Y. 1994: Prostaglandin E2 inhibits interleukin-6 release but not its transcription in human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor-alpha. Journal of Periodontology 65(12): 1122-1127

Schnyder, J.; Dewald, B.; Baggiolini, M. 1982: Prostaglandin E2 is a feed-back regulator of macrophage activation. Advances in Experimental Medicine and Biology 155: 535-540

Ekblad, U.; Erkkola, R.; Uotila, P. 1982: Prostaglandin E2 is only slightly metabolized in the fetal circulation of perfused human placenta. Prostaglandins Leukotrienes and Medicine 8(5): 481-488

Claeys, M.; Wechsung, E.; Herman, A.G.; Nugteren, D.H. 1981: Prostaglandin E2 is the prevalent metabolite of arachidonic acid formed by aortic tissue of the chicken. Archives Internationales de Pharmacodynamie et de Therapie 249(2): 312-315

Tsukatani, H.; Itami, T.; Matsuda, K. 1970: Prostaglandin E2 like activity in monkey lung. Chemical and Pharmaceutical Bulletin 18(1): 206-209

Cagen, L.M.; Lanier, S.M.; Baer, P.G. 1981: Prostaglandin E2 metabolism by isolated kidneys of New Zealand genetically hypertensive and normotensive rats. Biochemical Medicine 25(1): 98-105

Murray, J.L. 1982: Prostaglandin E2 modulation of human monocyte antibody-dependent cell-mediated cytotoxicity against human red blood cells. Cellular Immunology 71(1): 196-201

Rodríguez Muñiz, J.; Gómez Echevarría, A.H.; Miyares Cao, C.M.; Armas Cruz, A. 1981: Prostaglandin E2 obtained by semisynthetic procedures from Gorgonia plexaura homomalla cubesis. Study of its bronchodilator effect. Allergologia et Immunopathologia 9(4): 319-334

MacKenzie, I.Z.; Fry, A. 1981: Prostaglandin E2 pessaries to facilitate first trimester aspiration termination. British Journal of Obstetrics and Gynaecology 88(10): 1033-1037

Materia, A.; Money, S.R.; Jaffe, B.M. 1982: Prostaglandin E2 potentiates the protective effect of cimetidine against stress-induced gastric ulceration. Journal of Surgical Research 32(5): 471-476

Szerenyi, K.D.; Campos, M.; McDonnell, P.J. 1994: Prostaglandin E2 production after lamellar keratectomy and photorefractive keratectomy. Journal of Refractive and Corneal Surgery 10(4): 413-416

Nakayama, Y.; Shindo, T.; Akihama, T.; Miura, A.B. 1984: Prostaglandin E2 production by human bone marrow cells: a comparison with peripheral blood mononuclear cells. Tohoku Journal of Experimental Medicine 144(4): 417-423

Attallah, A.; Lee, J.B.; Ambrus, J.L.; Ambrus, C.M.; Karakousis, C.; Takita, H. 1984: Prostaglandin E2 production by human tumors. Defense mechanism against the host? A preliminary report. Research Communications in Chemical Pathology and Pharmacology 43(2): 195-201

Brown, W.W.; Zenser, T.V.; Davis, B.B. 1980: Prostaglandin E2 production by rabbit urinary bladder. American Journal of Physiology 239(5): F452-F458

Schultze, G.; Maiga, M.; Neumayer, H.H.; Wagner, K.; Keller, F.; Molzahn, M.; Nigam, S. 1984: Prostaglandin E2 promotes hypotension on low-sodium hemodialysis. Nephron 37(4): 250-256

Richelsen, B.; Eriksen, E.F.; Beck-Nielsen, H.; Pedersen, O. 1984: Prostaglandin E2 receptor binding and action in human fat cells. Journal of Clinical Endocrinology and Metabolism 59(1): 7-12

Carsten, M.E.; Miller, J.D. 1981: Prostaglandin E2 receptor in the myometrium: distribution in subcellular fractions. Archives of Biochemistry and Biophysics 212(2): 700-704

Emilie, D.; Crevon, M.C.; Galanaud, P. 1983: Prostaglandin E2 regulation of human specific B-cell response: interaction with a monocyte product. Clinical Immunology and Immunopathology 29(3): 415-423

Young, M.R.; Simmermaker, J.A. 1984: Prostaglandin E2 regulation of tumoristatic factor production by macrophage-like P388D1 cells. Journal of the National Cancer Institute 73(4): 959-962

Treves, A.J.; Ligumski, M.; Fuks, Z.; Haimovitz, A.; Rachmilewitz, D. 1982: Prostaglandin E2 secretion by subsets of human peripheral blood monocytes. Immunopharmacology 4(3): 267-276

Eppig, J.J. 1981: Prostaglandin E2 stimulates cumulus expansion and hyaluronic acid synthesis by cumuli oophori isolated from mice. Biology of Reproduction 25(1): 191-195

Mulholland, M.W.; Simeone, D.M. 1993: Prostaglandin E2 stimulation of acetylcholine release from guinea pig myenteric plexus neurons. American Journal of Surgery 166(5): 552-556

Sernka, T.J.; Caplan, J.E. 1982: Prostaglandin E2 stimulation of oxygen consumption in parietal cells and of H+ transport in gastric mucosa of the rat. Physiological Chemistry and Physics 14(2): 99-108

Anonymous 1974: Prostaglandin E2 synthesis in human epidermis and its inhibition by unsaturated fatty acids. Nutrition Reviews 32(1): 19-21

Gerritsen, M.E.; Printz, M.P. 1980: Prostaglandin E2 synthesis in pigeon aorta: comparison of atherosclerosis-resistant (Show Racer) and atherosclerosis-prone (White Carneau) breeds. Artery 8(1): 56-62

Yik, K.Y.; Dreidger, A.A.; Watson, W.C. 1982: Prostaglandin E2 tablets prevent aspirin-induced blood loss in man. Digestive Diseases and Sciences 27(11): 972-975

Boehm, F.H.; Killam, A.P.; Chambers, J.F.; Davidson, K.K. 1980: Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus. Obstetrics and Gynecology 55(6): 758-760

Goldstein, A.I.; Kent, D.R.; David, A. 1983: Prostaglandin E2 vaginal suppositories in the treatment of intractable late-onset postpartum hemorrhage. A case report. Journal of Reproductive Medicine 28(6): 425-426

Bolognese, R.J.; Corson, S.L. 1974: Prostaglandin E2 vaginal suppository as a midtrimester abortifacient. American Journal of Obstetrics and Gynecology 120(2): 281-284

Bolognese, R.J.; Corson, S.L. 1974: Prostaglandin E2 vaginal suppository as an early second trimester abortifacient. Obstetrics and Gynecology 43(1): 104-108

Kennedy, T.G. 1983: Prostaglandin E2, adenosine 3':5'-cyclic monophosphate and changes in endometrial vascular permeability in rat uteri sensitized for the decidual cell reaction. Biology of Reproduction 29(5): 1069-1076

Huang, C.C. 1981: Prostaglandin E2, collagenase, and protease levels in culture of rat tumor. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 89(4): 564-568

Young, I.R.; Thorburn, G.D. 1994: Prostaglandin E2, fetal maturation and ovine parturition. Australian and New Zealand Journal of Obstetrics and Gynaecology 34(3): 342-346

Kuhn, D.C.; Willis, A.L. 1973: Prostaglandin E2, inflammation and pain threshold in rat paws. British Journal of Pharmacology 49(1): 183P-184P

Venuto, R.C.; Donker, A.J. 1982: Prostaglandin E2, plasma renin activity, and renal function throughout rabbit pregnancy. Journal of Laboratory and Clinical Medicine 99(2): 239-246

Kuylenstierna, J.; Karlberg, B.E.; Morales, O. 1984: Prostaglandin E2, renin and angiotensin Ii in renovascular hypertension. Journal of Hypertension 2(4): 397-403

Köller, A.; Nürnberger, N.; Pflüger, H. 1983: Prostaglandin E2--an improvement in the therapy of bladder emptying disorders?. Zeitschrift für Urologie und Nephrologie 76(3): 145-149

Gobbetti, A.; Zerani, M. 1995: Prostaglandin E2-9-ketoreductase and prostaglandin F2 alpha activate brain aromatase to induce courtship in the male crested newt, Triturus carnifex. Hormones and Behavior 29(2): 267-277

Levine, R.A.; Kohen, K.R.; Schwartzel, E.H.; Ramsay, C.E. 1982: Prostaglandin E2-histamine in interactions on cAMP, cGMP, and acid production in isolated fundic glands. American Journal of Physiology 242(1): G21-G26

Lydyard, P.M.; Brostoff, J.; Hudspith, B.N.; Parry, H. 1982: Prostaglandin E2-mediated enhancement of human plasma cell differentiation. Immunology Letters 4(3): 113-116

Steven, K.; Lange, P.; Bukhave, K.; Rask-Madsen, J. 1981: Prostaglandin E2-mediated secretory diarrhea in villous adenoma of rectum: effect of treatment with indomethacin. Gastroenterology 80(6): 1562-1566

Balch, C.M.; Dougherty, P.A.; Cloud, G.A.; Tilden, A.B. 1984: Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery 95(1): 71-77

Fargeas, M.J.; Fioramonti, J.; Buéno, L. 1984: Prostaglandin E2: a neuromodulator in the central control of gastrointestinal motility and feeding behavior by calcitonin. Science 225(4666): 1050-1052

Johnson, J.M.; Hargrove, J.L.; Ellis, L.C. 1971: Prostaglandin F 1a induced stimulation of rabbit testicular contractions. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 138(1): 378-381

Goding, J.R.; Cain, M.D.; Cerini, J.; Cerini, M.; Chamley, W.A.; Cumming, I.A. 1972: Prostaglandin F 2 'the' luteolytic hormone in the ewe. Journal of Reproduction and Fertility 28(1): 146-147

Goding, J.R.; Cumming, I.A.; Chamley, W.A.; Brown, J.M.; Cain, M.D.; Cerini, J.C.; Cerini, M.E.; Findlay, J.K.; O'Shea, J.D.; Pemberton, D.H. 1971: Prostaglandin F 2 , the luteolysin in the mammal?. Gynecologic Investigation 2(1): 73-97

Lima, F.; Gimeno, M.F.; Goldraij, A.; Bedners, A.S.; Gimeno, A.L. 1971: Prostaglandin F 2 and motility of the myometrium isolated from ovariectomized rats. Effects of 17-beta estradiol. Life Sciences.(Part 1): Physiology and Pharmacology 10(17): 999-1008

Spellacy, W.N.; Gall, S.A. 1972: Prostaglandin F 2 and oxytocin for term labor induction. Journal of Reproductive Medicine 9(6): 300-303

Larsen, J.F.; Pedersen, P.H.; Sorensen, B. 1973: Prostaglandin F 2 as an oxytocic agent in the second and third trimesters. Ugeskrift for Laeger 135(7): 354-358

Sharma, S.C.; Hibbard, B.M.; Hamlett, J.D.; Fitzpatrick, R.J. 1973: Prostaglandin F 2 concentrations in peripheral blood during the first stage of normal labour. British Medical Journal 1(5855): 709-711

Vakhariya, V.R.; Sherman, A.I. 1972: Prostaglandin F 2 for induction of labor. American Journal of Obstetrics and Gynecology 113(2): 212-222

Cheah, S.F.; Khairuddin, Y. 1973: Prostaglandin F 2 for induction of labour. Medical Journal of Malaysia 27(3): 211-216

McCracken, J.A.; Carlson, J.C.; Glew, M.E.; Goding, J.R.; Baird, D.T.; Gréen, K.; Samuelsson, B. 1972: Prostaglandin F 2 identified as a luteolytic hormone in sheep. Nature: New Biology 238(83): 129-134

Willis, A.L.; Johnson, M.; Rabinowitz, I.; Wolf, P.L. 1972: Prostaglandin F 2 may induce sickle-cell crisis. New England Journal of Medicine 286(14): 783-784

Gromov, A.I.; Moiseeva, O.A.; Malina, N.V.; Gromova, N.V.; Orekhov, S.N. 1982: Prostaglandin F alpha and e content of the tissues of the snail Helix pomatia. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 18(3): 299-301

Findlay, J.K.; Colvin, N.; Swaney, J.; Doughton, B. 1983: Prostaglandin F and 13,14-dihydro-15-keto prostaglandin F in the endometrium and uterine flushings of sheep before implantation. Journal of Reproduction and Fertility 68(2): 343-349

Cox, R.I.; Thorburn, G.D.; Currie, W.B.; Restall, B.J.; Schneider, W. 1973: Prostaglandin F group (PGF), progesterone, and estrogen concentrations in the uteroovarian venous plasma of the conscious ewe during the estrous cycle. Advances in the Biosciences 9: 625-630

Lau, I.F.; Saksena, S.K.; Chang, M.C. 1974: Prostaglandin F in the uterine horns of mice with intrauterine devices. Journal of Reproduction and Fertility 37(2): 429-432

Lackritz, R.; Cohen, W.R.; Tulchinsky, D. 1980: Prostaglandin F production by tissue explants from term pregnancies. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 17(6): 585-589

McCracken, J. 1971: Prostaglandin F-2 alpha and corpus luteum regression. Annals of the new York Academy of Sciences 180: 456-472

Newball, H.H.; Keiser, H.R.; Lenfant, C. 1980: Prostaglandin F-2 alpha functions as a local hormone on human airways. Respiration Physiology 41(2): 183-197

Auletta, F.J.; Speroff, L.; Caldwell, B.V. 1973: Prostaglandin F-2 induced steroidogenesis and luteolysis in the primate corpus luteum. Journal of Clinical Endocrinology and Metabolism 36(2): 405-407

Hu, C.L. 1984: Prostaglandin F2 Alpha levels of the cerebrospinal fluid in patients with cerebrovascular diseases. Zhonghua Shen Jing Jing Shen Ke Za Zhi 17(3): 170-173

Lundström, V.; Bygdeman, M. 1980: Prostaglandin F2 alpha and E2 in primary dysmenorrhea. Advances in Prostaglandin and Thromboxane Research 8: 1455-1458

Vondra, V.; Erban, J.; Solcová, P. 1982: Prostaglandin F2 alpha and acetylcholine in pollen allergy. Casopis Lekaru Ceskych 121(52): 1616-1619

Liptrap, R.M. 1980: Prostaglandin F2 alpha and progesterone in experimental hypogalactia in sows. Research in Veterinary Science 29(2): 240-247

Milanov, S.; Belovezhdov, N.; Milkov, V.; Gurev, I.; Kiperova, B. 1981: Prostaglandin F2 alpha and renal hypertension. Vutreshni Bolesti 20(6): 54-58

Tamai, I.; Takei, T.; Maekawa, K.; Ohta, H. 1983: Prostaglandin F2 alpha concentrations in the cerebrospinal fluid of children with febrile convulsions, epilepsy and meningitis. Brain and Development 5(4): 357-362

Platkov, E.M.; Bril', E.E. 1983: Prostaglandin F2 alpha content of the blood of bronchial asthma patients. Terapevticheskii Arkhiv 55(3): 17-19

Poyer, J.F.; Millar, C.; Kaufman, P.L. 1995: Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscle. Investigative Ophthalmology and Visual Science 36(12): 2461-2465

Scott, J.E.; Persaud, T.V. 1981: Prostaglandin F2 alpha effects on the early mouse embryo. Research Communications in Chemical Pathology and Pharmacology 32(3): 549-552

De Gezelle, H.; Thiery, M.; Parewijck, W.; Decoster, J.M. 1980: Prostaglandin F2 alpha for interrupting pregnancy, managing intrauterine death and molar pregnancy and inducing labor. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 17(4): 362-367

Plunkett, S.S.; Stevenson, J.S.; Call, E.P. 1984: Prostaglandin F2 alpha for lactating dairy cows with a palpable corpus luteum but unobserved estrus. Journal of Dairy Science 67(2): 380-387

Crowe, M.A.; Enright, W.J.; Roche, J.F. 1994: Prostaglandin F2 alpha immunization of prepubertal beef heifers: effects of conjugate dose and timing of immunization relative to puberty on the onset of puberty and subsequent ovarian function. Journal of Reproductive Immunology 27(3): 227-240

Saksena, S.K.; Lau, I.F.; Chang, M.C. 1974: Prostaglandin F2 alpha implant-induced abortion: effect on progestin and luteinizing hormone concentration and its reversal by progesterone in rabbits, rats, and hamsters. Fertility and Sterility 25(10): 845-850

Castrillo, M.J.; Sánchez Ramos, J.E. 1974: Prostaglandin F2 alpha in evacuation of delayed abortion. 1. Intravenous administration. Acta Ginecologica 25(10): 759-770

Ziabkina, A.G.; Stepanova, I.I.; Markov, K.M. 1980: Prostaglandin F2 alpha in the blood plasma of children with bronchial asthma. Pediatriia 7: 38-39

Andrinopoulos, G.C.; Mendenhall, H.W. 1983: Prostaglandin F2 alpha in the management of delayed postpartum hemorrhage. American Journal of Obstetrics and Gynecology 146(2): 217-218

Sondheimer, S.J.; Flickinger, G. 1982: Prostaglandin F2 alpha in the peritoneal fluid of patients with endometriosis. International Journal of Fertility 27(2): 73-75

Serrero, G.; Lepak, N.M. 1995: Prostaglandin F2 alpha inhibits epidermal growth factor binding to cellular receptors on adipocyte precursors in primary culture. Biochemical and Biophysical Research Communications 212(3): 1125-1132

Luborsky, J.L.; Dorflinger, L.J.; Wright, K.; Behrman, H.R. 1984: Prostaglandin F2 alpha inhibits luteinizing hormone (LH)-induced increase in LH receptor binding to isolated rat luteal cells. Endocrinology 115(6): 2210-2216

Davidovitch, Z.; Shanfeld, J.L.; Lally, E. 1982: Prostaglandin F2 alpha is associated with alveolar bone cells: immunohistochemical evidence utilizing monoclonal antibodies. Progress in Clinical and Biological Research 101: 125-134

Egg, D.; Herold, M.; Rumpl, E.; Günther, R. 1980: Prostaglandin F2 alpha levels in human cerebrospinal fluid in normal and pathological conditions. Journal of Neurology 222(4): 239-248

McLean, M.P.; Billheimer, J.T.; Warden, K.J.; Irby, R.B. 1995: Prostaglandin F2 alpha mediates ovarian sterol carrier protein-2 expression during luteolysis. Endocrinology 136(11): 4963-4972

Kask, K.; Malmgren, L.; Odensvik, K. 1995: Prostaglandin F2 alpha metabolite levels following an embryo transfer procedure in the mare. Acta Veterinaria Scandinavica 36(1): 145-147

Satoh, K.; Kawai, Y.; Mitsuhashi, N.; Kinoshita, K.; Sakamoto, S. 1980: Prostaglandin F2 alpha metabolites in plasma and urine during pseudopregnancy in the rabbit. American Journal of Obstetrics and Gynecology 138(7 Part 1): 748-754

Gabrilevskaya, O.V.; Vogel, J.; Nobiling, R.H. 1994: Prostaglandin F2 alpha modulates responses of single cultured mesangial cell to arginine vasopressin. Prostaglandins Leukotrienes and Essential Fatty Acids 51(3): 195-201

Kredentser, J.V.; Embree, J.E.; McCoshen, J.A. 1995: Prostaglandin F2 alpha output by amnion-chorion-decidua: relationship with labor and prostaglandin E2 concentration at the amniotic surface. American Journal of Obstetrics and Gynecology 173(1): 199-204

Watanabe, T.; Waga, I.; Honda, Z.; Kurokawa, K.; Shimizu, T. 1995: Prostaglandin F2 alpha stimulates formation of p21ras-GTP complex and mitogen-activated protein kinase in NIH-3T3 cells via Gq-protein-coupled pathway. Journal of Biological Chemistry 270(15): 8984-8990

Macphee, C.H.; Drummond, A.H.; Otto, A.M.; Jimenez de Asua, L. 1984: Prostaglandin F2 alpha stimulates phosphatidylinositol turnover and increases the cellular content of 1,2-diacylglycerol in confluent resting Swiss 3T3 cells. Journal of Cellular Physiology 119(1): 35-40

Sarvas, K.; Angervo, M.; Koistinen, R.; Tiitinen, A.; Seppälä, M. 1994: Prostaglandin F2 alpha stimulates release of insulin-like growth factor binding protein-3 from cultured human granulosa-luteal cells. Human Reproduction 9(9): 1643-1646

Lepak, N.M.; Serrero, G. 1995: Prostaglandin F2 alpha stimulates transforming growth factor-alpha expression in adipocyte precursors. Endocrinology 136(8): 3222-3229

Fuchs, A.R.; Rasmussen, A.B.; Rehnström, J.; Toth, M. 1984: Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions. American Journal of Obstetrics and Gynecology 150(1): 27-32

Sahai, A.; Nissim, I.; Sandler, R.S.; Tannen, R.L. 1995: Prostaglandin F2 alpha- and 12-O-tetradecanoylphorbol-13-acetate-induced alterations in the pathways of renal ammoniagenesis. Journal of the American Society of Nephrology: Jasn 5(10): 1792-1798

Labhsetwar, A.P. 1971: Prostaglandin F2-alpha and the implantation process in the rat. Journal of Endocrinology 50(2): 353-354

Kirton, K.T.; Koering, M.J. 1973: Prostaglandin F2a and primate corpus luteum: a correlation of structure and function. Fertility and Sterility 24(12): 926-934

Marmo, E.; Vacca, C.; Di Nola, R.; Matera, A. 1974: Prostaglandin F2alpha (PGF 2alpha) and striated musculature. Il Farmaco; Edizione Scientifica 29(9): 720-726

Murri, S.; Melis, G.B.; Fruzzeti, F.; Paoletti, A.M.; Tallarico, N.; Fioretti, P. 1981: Prostaglandin F2alpha (PGF2alpha) and prolactin secretion under various experimental conditions. Minerva Ginecologica 33(6): 528-531

Brummer, H.C.; Craft, I.L. 1973: Prostaglandin F2alpha and labour. Acta Obstetricia et Gynecologica Scandinavica 52(3): 273-275

Nielsen, K.R.; Gregersen, E.; Larsen, J.F.; Olsen, C.E. 1974: Prostaglandin F2alpha and oxytocin compared with hypertonic saline and oxytocin for the induction of second trimester abortion. Acta Obstetricia et Gynecologica Scandinavica. Suppl 37: 57-60

Islam, M.S.; Ulmer, W.T. 1974: Prostaglandin F2alpha as bronchoconstrictor. Respiration; International Review of Thoracic Diseases 31(4): 332-342

Hibbard, B.M.; Sharma, S.C.; Fitzpatrick, R.J.; Hamlett, J.D. 1974: Prostaglandin F2alpha concentrations in amniotic fluid in late pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth 81(1): 35-38

Vernon, M.W.; Zavy, M.T.; Asquith, R.L.; Sharp, D.C. 1981: Prostaglandin F2alpha in the equine endometrium: steroid modulation and production capacities during the estrous cycle and early pregnancy. Biology of Reproduction 25(3): 581-589

Powell, W.S.; Hammarström, S.; Samuelsson, B. 1974: Prostaglandin F2alpha receptor in ovine corpora lutea. European Journal of Biochemistry 41(1): 103-107

Elias, J.A. 1973: Prostaglandin F2alpha vaginal pessaries for midtrimester abortion. Advances in the Biosciences 9: 581-584

Vanderheyden, K.; Dhont, M.; Vandekerckhove, D.; Vermeulen, A.; Thiery, M. 1974: Prostaglandin F2alpha: effect on cortisol, growth hormone, luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone. Ircs Journal of International Research Communications 2(3): 1164

Holtzman, M.J.; Zhang, V.; Hussain, H.; Roswit, W.T.; Wilson, J.D. 1994: Prostaglandin H synthase and lipoxygenase gene families in the epithelial cell barrier. Annals of the new York Academy of Sciences 744: 58-77

Wise, R.W.; Zenser, T.V.; Davis, B.B. 1983: Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. Carcinogenesis 4(3): 285-289

Zenser, T.V.; Mattammal, M.B.; Wise, R.W.; Rice, J.R.; Davis, B.B. 1983: Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis. Journal of Pharmacology and Experimental Therapeutics 227(3): 545-550

Reed, G.A.; Grafstrom, R.C.; Krauss, R.S.; Autrup, H.; Eling, T.E. 1984: Prostaglandin H synthase-dependent co-oxygenation of (+/-)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in hamster trachea and human bronchus explants. Carcinogenesis 5(7): 955-960

Morrison, L.D.; Eling, T.E.; Josephy, P.D. 1993: Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ. Mutation Research 302(1): 45-52

Morton, K.C.; King, C.M.; Vaught, J.B.; Wang, C.Y.; Lee, M.S.; Marnett, L.J. 1983: Prostaglandin H synthase-mediated reaction of carcinogenic arylamines with tRNA and homopolyribonucleotides. Biochemical and Biophysical Research Communications 111(1): 96-103

Rybicki, J.P.; Le Breton, G.C. 1983: Prostaglandin H2 directly lowers human platelet cAMP levels. Thrombosis Research 30(5): 407-414

Zehl, U.; Förster, W. 1984: Prostaglandin I2 (PG I2) fails to inhibit ADP induced platelet aggregation in vivo in rats. Prostaglandins Leukotrienes and Medicine 16(1): 45-56

Kelton, J.G.; Blajchman, M.A. 1980: Prostaglandin I2 (prostacyclin). Canadian Medical Association Journal 122(2): 175-179

Hokama, Y.; Matsuo, M.; Seto, D.S. 1983: Prostaglandin I2 (prostacyclin) formation in lung tissues of Swiss mice. Research Communications in Chemical Pathology and Pharmacology 42(1): 145-148

Gaylarde, P.M. 1981: Prostaglandin I2 and E1 and red cell deformability in raynaud's phenomenon and systemic sclerosis. British Medical Journal 283(6306): 1608-1609

Lifschitz, M.D.; Barnes, J.L. 1984: Prostaglandin I2 attenuates ischemic acute renal failure in the rat. American Journal of Physiology 247(5 Part 2): F714-F717

Slott, J.H.; Hall, K.; Clark, D.A.; Stuart, M.J. 1982: Prostaglandin I2 fails to influence red cell deformability. Prostaglandins Leukotrienes and Medicine 8(1): 21-22

Charo, I.F.; Shak, S.; Karasek, M.A.; Davison, P.M.; Goldstein, I.M. 1984: Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. Journal of Clinical Investigation 74(3): 914-919

Dave, J.R.; Knazek, R.A. 1980: Prostaglandin I2 modifies both prolactin binding capacity and fluidity of mouse liver membranes. Proceedings of the National Academy of Sciences of the United States of America 77(11): 6597-6600

Schillinger, E.; Prior, G. 1980: Prostaglandin I2 receptors in a particulate fraction of platelets of various species. Biochemical Pharmacology 29(17): 2297-2299

Mitsuma, T.; Nogimori, T. 1984: Prostaglandin I2 stimulates thyrotropin secretion in vivo and in vitro in rats. Endocrinologia Experimentalis 18(1): 53-58

Sprague, R.S.; Stephenson, A.H.; Lonigro, A.J. 1984: Prostaglandin I2 supports blood flow to hypoxic alveoli in anesthetized dogs. Journal of Applied Physiology: Respiratory Environmental and Exercise Physiology 56(5): 1246-1251

Claesson, H.E. 1980: Prostaglandin I2 synthesis and elevation of cyclic AMP levels in 3T3 fibroblasts. Biochimica et Biophysica Acta 618(3): 399-406

Hallenbeck, J.M.; Leitch, D.R.; Dutka, A.J.; Greenbaum, L.J.; McKee, A.E. 1982: Prostaglandin I2, indomethacin, and heparin promote postischemic neuronal recovery in dogs. Annals of Neurology 12(2): 145-156

Fukushima, M.; Sasaki, H.; Fukushima, S. 1994: Prostaglandin J2 and related compounds. Mode of action in G1 arrest and preclinical results. Annals of the new York Academy of Sciences 744: 161-165

Ylikorkala, O.; Jouppila, P.; Ylöstalo, P.; Järvinen, P.A. 1974: Prostaglandin abortions in an outpatient ward. Duodecim; Laaketieteellinen Aikakauskirja 90(19): 1308-1316

Juttmann, J.R.; Visser, T.J.; Buurman, C.; de Kam, E.; Birkenhäger, J.C. 1981: Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. British Medical Journal 282(6273): 1349-1352

Jones, M.A.; Harper, M.J. 1983: Prostaglandin accumulation by isolated uterine endometrical epithelial cells from six-day pregnant rabbits. Biology of Reproduction 29(5): 1201-1209

Coupar, I.M. 1980: Prostaglandin action, release and inactivation by rat isolated perfused mesenteric blood vessels. British Journal of Pharmacology 68(4): 757-763

Güllner, H.G. 1983: Prostaglandin actions on the adrenergic nervous system. Klinische Wochenschrift 61(11): 533-540

Toppozada, M.; Bygdeman, M.; Wiqvist, N. 1972: Prostaglandin administration for induction of mid-trimester abortion in complicated pregnancies. Lancet 2(7792): 1420-1421

Mutoh, H. 1984: Prostaglandin analogs for the treatment of peptic ulcer. Nihon Rinsho. Japanese Journal of Clinical Medicine 42(1): 125-129

Hayashi, M.; Miyake, H.; Kori, S.; Tanouchi, T.; Wakatsuka, H.; Arai, Y.; Yamato, T.; Kajiwara, I.; Konishi, Y.; Tsuda, T.; Matsumoto, K. 1980: Prostaglandin analogues possessing antinidatory effects. 1. Modification of the omega chain. Journal of Medicinal Chemistry 23(5): 519-524

Hayashi, M.; Arai, Y.; Wakatsuka, H.; Kawamura, M.; Konishi, Y.; Tsuda, T.; Matsumoto, K. 1980: Prostaglandin analogues possessing antinidatory effects. 2. Modification of the alpha chain. Journal of Medicinal Chemistry 23(5): 525-535

Golub, M.S.; Berger, M.E.; Sambhi, M.P.; Eggena, P. 1981: Prostaglandin and angiotensin converting enzyme inhibition: effect on blood pressure, renin activity and renal function in hemorrhaged conscious rabbits. Clinical and Experimental Hypertension 3(3): 477-495

Kuramoto, J. 1974: Prostaglandin and blood platelets. Horumon to Rinsho. Clinical Endocrinology 22(8): 915-926

Nekrasova, A.A.; Nikolaeva, E.N.; Khukharev, V.V. 1968: Prostaglandin and depressor function of the kidneys in the pathogenesis of hypertension. Kardiologiia 8(12): 16-22

Sato, M.; Yasujima, M.; Abe, K. 1981: Prostaglandin and its receptors. Nihon Rinsho. Japanese Journal of Clinical Medicine 39(9): 3039-3043

Toyoda, T. 1974: Prostaglandin and pancreatic function: endocrine and exocrine functions. Horumon to Rinsho. Clinical Endocrinology 22(4): 485-492

Johansson, C.; Bergström, S. 1982: Prostaglandin and protection of the gastroduodenal mucosa. Scandinavian Journal of Gastroenterology. Suppl 77: 21-46

Mitsuhashi, S.; Ito, H. 1974: Prostaglandin and renal function. (III). the effect of PGA-2, on the urinary solutes excretion. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 65(10): 648-653

Ito, H.; Mitsuhashi, S.; Momose, G. 1974: Prostaglandin and renal function. I. the effect of prostaglandin A2 on the PSP excretion. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 65(1): 44-54

Ito, H.; Mitsuhashi, S. 1974: Prostaglandin and renal function. the effect of prostaglandin E1 injected into renal artery on selective renal arteriogram of man. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 65(4): 229-233

Bolton, C.; Gordon, D.; Turk, J.L. 1984: Prostaglandin and thromboxane levels in central nervous system tissues from rats during the induction and development of experimental allergic encephalomyelitis (EAE). Immunopharmacology 7(2): 101-107

Hechtman, H.B.; Huval, W.V.; Mathieson, M.A.; Stemp, L.I.; Valeri, C.R.; Shepro, D. 1983: Prostaglandin and thromboxane mediation of cardiopulmonary failure. Surgical Clinics of North America 63(2): 263-283

Kass, M.A.; Holmberg, N.J.; Smith, M.E. 1981: Prostaglandin and thromboxane synthesis by microsomes of inflamed rabbit ciliary body--iris. Investigative Ophthalmology and Visual Science 20(4): 442-449

Spolarics, Z.; Tanács, B.; Garzó, T.; Mandl, J.; Mucha, I.; Antoni, F.; Machovich, R.; Horváth, I. 1984: Prostaglandin and thromboxane synthesizing activity in isolated murine hepatocytes and nonparenchymal liver cells. Prostaglandins Leukotrienes and Medicine 16(3): 379-388

Bennett, A. 1974: Prostaglandin antagonists. Advances in Drug Research 8: 83-118

Kuehl, F.A.; Humes, J.L.; Mandel, L.R.; Cirillo, V.J.; Zanetti, M.E.; Ham, E.A. 1971: Prostaglandin antagonists: studies on the mode of action of polyphloretin phosphate. Biochemical and Biophysical Research Communications 44(6): 1464-1470

Ehrenpreis, S. 1981: Prostaglandin as a modulator of acetylcholine release in guinea pig myenteric plexus. Progress in Lipid Research 20: 505-509

Bygdeman, M. 1980: Prostaglandin as an abortifacient agent. Lakartidningen 77(7): 549-551

Strom, T.B.; Carpenter, C.B. 1983: Prostaglandin as an effective antirejection therapy in rat renal allograft recipients. Transplantation 35(4): 279-281